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Abstract
The development of new and improved biomaterials is essential for tissue engineering and
regenerative medicine applications. Amino acid-based polyphosphazenes are being explored
as scaffold materials for tissue engineering applications due to their non-toxic degradation
products and tunable material properties. This work focuses on the synthesis of nonfunctional and novel functional poly[(amino acid ester)phosphazene]s using a facile method
of thermal ring opening polymerization followed by one-pot room temperature substitution.
The family of polyphosphazenes developed in this work is based on L-alanine (PP-A’s), Lphenylalanine (PP-F’s), and L-methionine (PP-M’s) with L-glutamic acid imparting the
functionality. Characterization of these materials demonstrated that the one-pot substitution
was

successful

in

developing

mono-

and

co-substituted

poly[(amino

acid

ester)phosphazene]s. Cytotoxicity studies on two-dimensional films showed these materials
to be compatible with NIH-3T3 fibroblasts over the five-day study. The PP-F’s also showed
significantly enhanced cell viability over tissue culture polystyrene at day 1 (p<0.001) and
day 3 (p<0.01). As a proof of concept, electrospinning of PP-A100 blended with
poly(caprolactone) (PCL) (50% PP-A100/50% PCL) was conducted to fabricate threedimensional

scaffolds.

Overall,

this

study

has

shown

that

poly[(amino

acid

ester)phosphazene]s can be synthesized with good yields and better reaction conditions,
leading to materials with promising cytocompatibility for use in biomedical applications.
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Chapter 1
1
1.1

Scope and Thesis Outline
Scope

As the fields of tissue engineering and regenerative medicine continue to emerge as
promising alternatives to current treatment options for failed or otherwise diseased
tissues, so too has the development of suitable biomaterials.1 Materials-mediated tissue
engineering is the most frequently employed strategy, where a porous scaffold, which is
ideally degradable, acts as a support for the developing tissue either in vitro or in vivo.
The scaffolds themselves must possess specific material and biological characteristics,
such as desirable mechanical properties, degradation rates that parallel tissue formation,
and biocompatibility, to ensure their success in tissue engineering applications.1 As such,
numerous natural and synthetic materials have been investigated for their use in
biomedical applications.2-4 Natural materials, like cellulose, chitosan, and collagen, have
been extensively studied due to their inherent biocompatibility and favourable cellmaterial interactions; however, they fall short as ideal materials due to their uncontrolled
degradation rates, poor mechanical properties, and batch-to-batch variability.4 Synthetic
polymers, on the other hand, have shown to be an improvement over natural materials
with their tunable and well-controlled mechanical properties and degradation rates, ease
of processing, and availability.5,
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That being said, degradable synthetic polymers, like

poly(acids), have their own drawbacks such as the formation of acidic degradation
products.7-9 Another limitation of synthetic materials is their inability to instruct cells
since they do not contain the biochemical cues that are present on the native extracellular
matrix, which direct proper tissue formation.10, 11 Therefore, degradable biomaterials that
can be tailored with respect to mechanical and degradation properties to suit their
intended applications and that degrade into non-toxic products are being actively
pursued.1, 5
Polyphosphazenes, especially poly[(amino acid ester)phosphazene]s, have been shown to
have tunable material properties and degrade into non-toxic degradation products that are
easily dealt with by the body, making them great candidates for use as scaffold
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biomaterials.12, 13 Since these materials are based on amino acids, it is also possible to
incorporate functionality into the polymers, which would allow for subsequent
attachment of biomolecules shown to improve cell-material properties, potentially
overcoming the main inadequacy of current synthetic materials. Current synthetic
methods for the fabrication of poly[(amino acid ester)phosphazene]s are cumbersome14
and development of a facile synthesis technique would make studying these materials
more accessible. With increased accessibility of poly[(amino acid ester)phosphazene]s,
these materials could be studied for their utility in a wider range of applications not just
orthopaedics, which has been the main application to date.15 Also, the facile synthesis
would allow for the development of novel co-substituted poly[(amino acid
ester)phosphazene]s with functional handles for biomolecule conjugation. In this work, a
facile synthesis of poly[(amino acid ester)phosphazene]s was developed and the resulting
materials were characterized extensively, investigated for cytotoxicity, and explored for
their potential in fabricating three-dimensional constructs.

1.2

Thesis Outline

This thesis contains five chapters. Chapter 2 provides an in-depth literature review of
tissue engineering, requirements of scaffold biomaterials, current natural and synthetic
materials and their limitations, the synthesis of polyphosphazenes, and the suitability of
polyphosphazenes as biomaterials in terms of biocompatibility, degradability, and
mechanical properties. The rationale and objectives for this work are also included at the
end of Chapter 2. Chapter 3 describes the materials and methods for the synthesis of the
poly[(amino acid ester)phosphazene]s materials, as well as the setup parameters and
experimental conditions for characterization, cell studies, and electrospinning
experiments. Chapter 4 presents and discusses all research findings of this work. Lastly,
Chapter 5 provides a general conclusion of the major findings in this study and future
directives for this project.
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Chapter 2
2
2.1

Literature Review, Objectives, and Rationale*
Tissue Engineering Methodology

There are four main strategies of tissue engineering that could be explored for tissue
repair and remodeling, cell transplantation, scaffold transplantation, and two forms of
cell-seeded scaffold transplantation. The cell transplantation strategy involves simply
injecting cells, whether they are stem cells or primary cells, to the damaged area and
allowing the cells to interact with the natural extracellular matrix (ECM) and mature into
working tissue in vivo.

In this case, the host body serves as the “bioreactor” that

produces the necessary mechanical stimulation and other signals to guide the maturation
and remodeling process. A limitation of this technique is that despite injection of the cells
to the damaged tissue, functional tissue generation is not guaranteed.16 The rejection of
the cells by the host’s immune system can also be problematic as cell sources are
typically from donors or sources other than the patients themselves.17, 18 The new cells
are also required to secrete their own ECM support system to fully integrate with the
existing tissue and if the necessary cues are not received by the cells this may not occur.19
The second strategy of tissue engineering tackles the development of new tissues from a
scaffold-based approach. In this approach, an unseeded scaffold, which can be based on
natural4, 5, 10 or synthetic material1, 5, is implanted directly into the patient and relies on
the already present neighboring cells to migrate and infiltrate the scaffold. The types of
scaffolds used in this technique can range from natural polymers to synthetic materials,
both of which maybe either stable or degradable. If cell migration cues on the scaffold are
missing or the cells do not interact favourably with the material, infiltration may be poor,
leading to a tissue with limited functionality and poor success rates.20

*

Parts of this chapter have been published: Baillargeon, Amanda L; Mequanint, Kibret, Biodegradable
Polyphosphazene Biomaterials for Tissue Engineering and Delivery of Therapeutics. Biomed. Res. Int. vol.
2014, Article ID 761373, 16 pages, 2014. doi:10.1155/2014/761373
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The last two paradigms of tissue engineering both rely on the use of an external cell
source and scaffold to create the new tissue.

The first type, cell-seeded scaffold

implantation, involves transplanting the scaffold into the patient following seeding the
cells onto the scaffold and allowing them to begin to adhere. In this method, the new
tissue relies on the patient’s body to act as the “bioreactor” for in vivo tissue maturation
and remodeling, while the cell-seeded scaffold receives signals from the surrounding
tissues and experiences mechanical forces and other stimuli to properly guide the tissue
maturation process. In the second type, in vitro tissue engineering (Figure 2.1), the cellseeded scaffold is allowed to mature in an artificial bioreactor in vitro prior to
implantation in the patient. In the bioreactor, the scaffold and cells are subjected to
appropriate forces, such as pulsatile flow and shear forces simulating those experienced
in native vessels for the development of tissue-engineered blood vessels, in order to
improve the maturation process to form completely functional tissues prior to
implantation.16 These stimuli, along with other factors including chemical signals, have
been shown to affect the development of functionally viable tissues, especially the
phenotype of vascular smooth muscle cells in vascular tissue engineering, and therefore
are important in generating useful tissue-engineered graft materials.21

These two

methods often include the incorporation of biomolecules alongside the cells and scaffold
that can improve cell-material interactions and enhance signaling for proper development
of a functional tissue. These biomolecules are typically growth factors and other small
protein molecules that can direct the proliferation, migration, and adhesion of cells onto
the scaffold material.22 The scaffolds themselves serve as a temporary template for the
cells to proliferate on until they are capable of secreting their own natural ECM as
support, and therefore must have the appropriate cell-material interactions and material
properties. If biostable materials are selected, it is important to consider not only the
mechanical properties of the scaffold material, but also the characteristics of the scaffold
and newly secreted ECM together, making sure that these match the material properties
of the native tissue. If a degradable material is chosen, it is ideal for the degradation rate
of the material to be comparable to the rate of secretion of the ECM by the cells. Overall,
ideal materials for all forms of scaffold-guided tissue engineering are yet to be realized
and are still under investigation, which is the basis for this research.
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Figure 2.1: A diagrammatic representation of the in vitro tissue engineering process;
where a cell-seeded scaffold is matured in vitro in a bioreactor prior to implantation
into the patient.

2.2

Requirements of Tissue Engineering Scaffolds

In order for a scaffold to be successful in tissue engineering applications it should mimic
the natural ECM of the tissue that is being repaired, regenerated, or replaced in both
material and biological properties.23,

24

By mirroring the ECM, the likelihood of

developing functional tissues is improved by encouraging proper cell proliferation,
migration, adhesion, and tissue assembly. The scaffolds themselves can be based on
either natural polymers, such as collagen, elastin, chitosan, and hyaluronic acid, or
synthetic polymers designed to mimic natural materials.4,

5, 10

Another key factor to

consider is the wide range of ECM morphology and structural arrangement across tissue
types, which is important for directing proper cell growth, and should therefore be closely
emulated in the natural and synthetic scaffolds using appropriate fabrication methods.25
The biological and material properties of scaffolds, described in detail below, are one of
the remaining critical issues in tissue engineering and serve as a guideline for the
development of new scaffold biomaterials.1
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The material properties that are important to consider are mechanical properties, porosity,
processability, degradability, surface chemistry, and sterilizability.

In terms of

mechanical properties, the materials must be physically strong in order to withstand
normal forces experienced within the specific type of tissue being engineered.26 For
example, in blood vessels the tissues experience shear forces and pulsatile blood flow, so
the materials should have adequate tensile strength and elastic modulus to endure these
forces.27 The natural ECM is highly porous allowing for substantial cell infiltration and
the development of complex tissues, likewise, the scaffold materials should be porous
and give cells the necessary space to penetrate, explore, and adhere throughout the 3-D
scaffold.28-30 Along with high porosity, there should also be a high surface area-tovolume ratio and appropriate pore diameters to accommodate the type of cells seeded into
the structure. This ensures that the cells are not only capable of infiltrating through the
pores, but also have sufficient surface area on which they can adhere. It is also important
that the pores of the scaffold are uniformly distributed across the 3-D construct and that
the pores are interconnected, allowing the cells to explore freely throughout the entire
matrix without encountering blockages. By selecting an appropriate fabrication
technique, such as freeze drying, solvent casting/particulate leaching, or electrospinning,
the desired characteristics of the scaffold can be achieved, such as a specific average pore
size and structural arrangement,.29-32 In solvent casting/particulate leaching methods, for
example, the pore size of the resulting scaffold can be well controlled by selecting a
porogen of appropriate diameter and selectively dissolving these out of the scaffold once
the polymer matrix is fully set.33, 34 Some limiting factors to consider when selecting a
fabrication method is the processability of the material, including properties such a
melting temperature (Tm), glass transition temperature (Tg), decomposition temperature
(Td), and solubility in appropriate solvents. For instance, solvent casting/particulate
leaching cannot be employed if there are no two solvents available that selectively
dissolve only the polymer in one and only the porogen in the other.33 The degradability
of scaffolds was described above in scaffold-based tissue engineering (Section 2.1),
although if degradable materials are to be used, it should be noted that their degradation
rate should coordinate well with the secretion rate of the new ECM by the cells. This will
ensure adequate mechanical strength of the scaffold and that there is sufficient support
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material for the proliferating cells.32, 35 Cells not only migrate along the scaffold surface,
but they also form focal adhesions and interact with the material itself. In order to
improve cell-material interactions and encourage the proliferation and adhesion of the
cells throughout the scaffold, it is important to include surface chemistry that is
favourable for cells on the materials.30, 36 In synthetic polymers this can be realized by
incorporating functional handles on the material surface that allow for the attachment of
biomolecules known to enhance cell-material interactions and cell proliferation. Lastly,
as these materials will eventually be implanted in patients, they must be sterilizable to
minimize the chance of bacterial and other small organismal infections in the patient
from the tissue-engineered constructs.
The biological requirements of scaffolds have been touched upon in the material
properties discussion, although the key traits they must possess include biocompatibility
and promotion of cell proliferation and adhesion. Considering the fact that these materials
will undoubtedly be used in vivo, they must not elicit immune response in the patients
that would be harmful to their well-being, including any degradation products in the case
of degradable materials. As such, materials are studied extensively in vitro and in vivo
prior to clinical trials, exploring cytoxicity, cell morphology, and inflammatory response,
to name a few.37 The tissue-engineered product, including the scaffold, must also interact
favourably and incorporate well with the existing tissues.
In conclusion, it is necessary to consider both the material and biological properties of
both natural polymers and synthetic materials used for scaffold fabrication, like those
described in the proceeding sections, to ensure they are well-suited for their intended
tissue engineering application.
2.2.1

Natural Polymers

Natural materials for scaffolds are often based on ECM components such as collagen3, 29,
38, 39

, fibrinogen40-42, hyaluronic acid43-45 and glycosaminoglycans (GAGs)46, 47 since these

materials have the bioactivity and compatibility required of a scaffold biomaterial. Other
natural materials such as chitosan, gelatin, and cellulose4, 48 are also known to be highly
biocompatible and therefore have been extensively studied for tissue engineering and
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other biomedical applications. The main advantage of natural materials is that they
intrinsically contain biological cues and signal molecules required for proper cell
adhesion and migration, which are lacking with unmodified synthetic materials, thus
limiting suitable cell-material interactions. Recently, Chen et al.25 developed knit silkcollagen scaffolds for tendon tissue engineering applications, that when seeded with
human embryonic stem cell-derived mesenchymal stem cells caused overexpression of
scleraxis; a tendon differentiation marker protein by the cells ideal for tendon
regeneration. Also, He et al.

49

fabricated aligned electrospun scaffolds of cellulose

nanocrystal reinforced nanocomposites for tissue engineering applications. The scaffolds
showed improved tensile and elastic properties and displayed non-toxic behavior in
toxicity assays with primary human dental follicle cells. The main drawbacks of natural
materials are their inadequate mechanical strength, uncontrolled degradation rates, poorly
defined structure, batch-to-batch variability, and limitations with purification and
sterilization processes leading to immunorejection.1,

4

These limitations have directed

researchers to investigate synthetic polymers as an alternative to natural materials.
2.2.2

Biodegradable Synthetic Polymers

Biodegradability is a desirable feature of a biomaterial used in tissue engineering since
the goal for it is to act as a temporary scaffold, holding the growing tissue in place until
the natural ECM has developed sufficiently. Beyond that point, the scaffold should break
down into non-toxic degradation products capable of being disposed of by the body,
leaving only the newly formed tissue. Synthetic polymers have the advantages of being
relatively inexpensive and readily available over natural materials.

They also have

tunable material properties that can be matched to the intended application, whereas
natural polymers have set material properties that limit their use in a range of
applications. There are a wide variety of synthetic biodegradable polymers that have
been, and continue to be, explored, including polyesters, polyanhydrides, polyacetals, and
poly (α-amino acids).50-55 Recently, Kim et al.56 fabricated a poly(ethylene glycol)
dimethacrylate and gelatin methacrylate-based hydrogel scaffold with controlled stiffness
and degradation properties for use in vascular tissue engineering. The scaffold was
shown to improve human umbilical vein endothelial cell attachment with elongated
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morphology showing progress towards improved in vivo endothelialization of tissueengineered small diameter vascular grafts, which has previously been a limitation in that
field. Amino acid-based synthetic polymers have been of great interest for biomedical
applications due to the fact that part of their degradation products are naturally occurring
amino acids, which are handled well by the body. Poly(ester amide)s53, 55 are one branch
of these polymers and have been shown not only to be biocompatible with various cell
types, but are also capable of being formed into 3-D constructs via various scaffold
fabrication techniques. Despite their improvement over natural polymers with regards to
degradation and mechanical properties, synthetic polymers have their own limitations.
Control of mechanical and degradation properties of synthetic polymers are limited when
the synthesis of materials is based on a single monomer, such as the case with polyesters.
Another common problem with synthetic polymers, such as poly(lactic acid) (PLA), is
the formation of acidic products during the degradation process which leads to
diminished mechanical strength of the material and compromised cell function in the
acidic environment.7-9 Unfunctionalized synthetic materials have a tendency to interact
poorly with cells due to the lack of biological signaling molecules present on the material
surface, unlike the native ECM which is rich in biomolecules for proper cell-material
interactions. The quest for biomaterials with tunable degradation rates and mechanical
properties, but that also maintain cell function and lack the formation of toxic degradation
products is an active area of research.6, 57
2.2.3

Biomimetic Materials

In order to improve the efficiency of interactions between synthetic polymers and cells,
the materials are often modified, either chemically or physically, prior to seeding cells
into the scaffold materials. Typical biological cues present on the natural ECM include
hormones, growth factors, and other small protein molecules, which direct cell adhesion,
proliferation, and migration. These molecules can be incorporated into synthetic materials
via bulk or surface modifications, although bulk modifications can significantly alter the
material properties of polymers.11 Surface alterations, on the other hand, only slightly
change the material properties of the polymers, thus maintaining the mechanical strength
of the scaffolds after modification.

Physical attachment of biomolecules is usually
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achieved via adsorption, which relies on non-covalent bonding (hydrophobic interactions,
hydrogen bonding, etc.). The main disadvantage of this method is that the biochemical
signals can leach away from the scaffold when exposed to culture media, potentially
resulting in a diminished effect of the biomolecule on cell-material interactions. When
chemical modification is used instead, the molecules are retained at the scaffold surface
by covalent linkages, which are not disrupted when the scaffold is submerged in culture
media, leading to prolonged biomolecule-mediated cell-material interactions.11 Chemical
linking of the bioactive compound to the material is limited by the availability of
functional groups on the surface of the materials which can be reacted with available
reactive sites on the biomolecule. This can be overcome by developing biomaterials that
contain reactive groups as functional handles for biomolecule conjugation, like the
carboxylic acid group of glutamic acid that has been explored in this work.
2.2.4

Scaffold Fabrication

In order for a biomaterial to be useful in tissue engineering applications, it must be
processable into a 3-D construct since natural tissues are inherently three-dimensional.
Traditional fabrication methods that have been studied extensively include freeze-drying,
fiber bonding, and solvent casting/particulate leaching.33, 51, 58 More recently, researchers
have been exploring electrospinning as a scaffold fabrication method due to its versatility
in forming fibers with diameters from the micron range down to the nanometer range.59, 60
The non-woven fibrous mats can also be collected and formed into specific construct
shapes, such as tubular for application in vascular tissue engineering, based on the type of
collector used and other spinning modifications.11,

60

The electrospinning process

involves the application of theories of electrostatic repulsion and surface tension,
resulting in the formation of a very small jet of polymer solution, which is then collected
as fibers on a collector. The general setup for electrospinning includes a high voltage DC
power supply, a syringe pump and syringe containing the polymer solution, and a
grounded collector upon which the fibers are deposited.

A solution containing the

desired concentration of polymer in a suitable solvent is prepared and loaded into a
syringe secured on the syringe pump. A needle on the end of the syringe is attached to
the high voltage source and a ground is attached to the collector, which can be stationary
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or rotating. The syringe pump begins to push the polymer solution into the needle tip
where the voltage induces a charge on the solution. Within the needle tip there is a fine
balance between the surface tension forces keeping the solution together and the
electrostatic repulsive forces driving the solution to spread. When the electrostatic forces
exceed the surface tension, a polymer jet escapes the needle and begins to travel towards
the grounded collector.60,

61

During flight, the polymer jet experiences whipping

instability, which increases travel time and path length to the collector. This increase in
travel time allows sufficient time for the majority of the solvent to evaporate, leaving
only the polymer behind as fibers on the collector and decreasing fiber diameter.30, 62, 63
By optimizing the solution and processing variables (e.g. solvent, concentration, voltage,
distance to the collector, flow rate, needle diameter, etc.), fibers with well-defined
diameters and morphology are achievable, which in turn affects the construct’s
mechanical properties.63-65 Overall, electrospinning is an ideal process for developing
3-D scaffolds for tissue engineering applications due to its relatively inexpensive setup
and adaptability for numerous applications.

2.3

Synthesis of Polyphosphazenes

Sustained research towards new biomaterials for tissue engineering and regenerative
medicine applications has led to the utilization of polyphosphazenes as a class of novel
materials.

Polyphosphazenes are comprised of an inorganic backbone of repeating

phosphorus and nitrogen atoms with alternating single and double bonds (Figure 2.2,
Structure 1c). Extending from each of the phosphorus atoms are two organic side chains,
which can range from alkoxy and aryloxy substituents to amino acids, giving a large
variety of potential polymers. Changing the organic side groups and their ratios, if
multiple different side groups are attached to the same polymer backbone, allows
substantial tunability of the physical, mechanical, and degradation properties of the
material. Therefore, altering the organic substituents can be quite useful in tailoring the
mechanical properties and degradation rates of the biomaterial to suit the desired tissue
engineering application, such as bone tissue or blood vessels, which require drastically
different properties.
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Figure 2.2: Structures of various polyphosphazenes including steroidal substituents
(2), carbohydrates (3), amino acid esters (4), and side chain bound amino acid esters
(5), to name a few.
The synthesis of polyphosphazenes, as shown in Scheme 2.1, are typically synthesized
via a two-step reaction, beginning with the thermal ring opening polymerization of
hexachlorocyclotriphosphazene (1a), the cyclic trimer, to the linear
poly[(dichloro)phosphazene] (1b) precursor. Next, the organic side chains are attached to
the polymer backbone through a nucleophilic macromolecular substitution of the organic
substituents for the phosphorus-bound chlorine atoms.66-68 The following two sections
will succinctly describe the individual steps of poly(organophosphazene) synthesis,
showing the different chemical routes previously reported and the vast range of materials
that can be generated.
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2.3.1

Polymerization to Poly[(dichloro)phosphazene]

2.3.1.1
Although

Thermal Ring Opening Polymerization – Bulk Phase
the

thermal

ring

polymerization

of

the

trimer

(1a)

to

linear

poly[(dichloro)phosphazene] was attempted in the late 1800s by H. N. Stokes69, a useful
material that was soluble and capable of being functionalized was not realized until the
1960s. The initial thermal ring opening polymerization performed by Stokes led to a
product that was insoluble, due to crosslinking, and that was readily susceptible to
hydrolysis when exposed to moisture. In 1965, Allcock and Kugel70 were able to
synthesize linear poly[(dichloro)phosphazene] through a well-controlled thermal ring
opening polymerization from the cyclic trimer hexachlorocyclotriphosphazene according
to Scheme 2.1. The product obtained was soluble, allowing it to be modified further by
macromolecular substitution of the reactive P-Cl bonds with organic and organometallic
nucleophiles. The thermal ring opening polymerization technique developed by Allcock
et al. is the most commonly used route to prepare the linear poly[(dichloro)phosphazene]
precursor.15, 67 A typical process involves reacting hexachlorocyclotriphosphazene trimer,
which was purified via sublimation techniques prior to reaction, at 250°C over 5 days in
an evacuated polymerization tube with continuous rocking of the reaction vessel. At this
point, soluble poly[(dichloro)phosphazene] has been formed and can be purified and
functionalized via the macromolecular substitution reaction (Scheme 2.1, 1a  1b).67
The yields obtained for these reactions reached a maximum of 75%.
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Scheme 2.1: Scheme showing the synthesis and functionalization of
poly[(dichloro)phosphazene] (1b) in the overall synthesis of polyphosphazenes from
hexachlorocyclotriphosphazene (1a) via the thermal ring opening polymerization
method.15
Despite the success of this reaction, researchers have explored other ways of forming
linear poly[(dichloro)phosphazene] in order to overcome some of the limitations of the
thermal ring opening polymerization since it requires specialized equipment, the use of
extreme temperatures, and high purity of the starting trimer.
2.3.1.2

Thermal Ring Opening Polymerization – Solution Phase

In 1990, Magill and co-workers71 developed a new solution phase ring opening
polymerization method for the synthesis of poly[(dichloro)phosphazene], which
eliminated the need for a specialized oven that allowed for continuous rocking of the
sample throughout the reaction. Also, the new Magill method substantially decreased the
reaction time from 5 days down to roughly one hour. The Magill method used a threeneck round bottom flask as the reaction vessel, which allowed for the attachment of a
reflux condenser and a gas inlet for N2 bubbling (to protect the hydrolytically sensitive
polymer from moisture).

In their method, they dissolved the trimer in 1,2,4-

trichlorobenzene and added small amounts of sulfamic acid (HSO3(NH2)) and calcium
sulfate dihydrate (gypsum, CaSO42 H2O) as catalyst and promoter, respectively
(Scheme 2.2). They allowed the mixture to react at reflux with dry N2 bubbling and
stirring until the solution was sufficiently viscous, which was approximately 45 to 60
minutes depending on the experiment. The experimenter needed to be attentive to the
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reaction because if it was allowed to proceed beyond this point crosslinking occurred and
the linear poly[(dichloro)phosphazene] was no longer useful as it was insoluble. They
obtained yields of approximately 35% using this method. A major drawback of this
method over the bulk polymerization is that it uses solvents, which are expensive and can
be problematic for biocompatibility if they are not fully removed prior to cell seeding and
implantation, and the necessity of the experimenter to be ever present, unlike the bulk
phase TROP that can be controlled by a self-timed oven.
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Scheme 2.2: Reaction scheme for the solution phase thermal ring opening
polymerization of hexachlorocyclotriphosphazene (cyclic trimer) to linear
poly[(dichloro)phosphazene] using a sulfamic acid catalyst and calcium sulfate
dehydrate promoter – The Magill Method.
2.3.1.3

“Living” Cationic Polymerization

Polymerization methods that do not rely on the thermal ring opening of
hexachlorocyclotriphosphazene

have

also

been

reported

in

poly[(dichloro)phosphazene].72-80 In 1995, Allcock and co-workers

the
75

synthesis

of

proposed a room

temperature synthesis of linear poly[(dichloro)phosphazene] that overcame the obstacle
of high temperature synthesis experienced with the previously described ring opening
polymerization, both in the bulk and solution phase. In their research, they developed a
synthesis of poly[(dichloro)phosphazene] from the phosphorus pentachloride (PCl5)
initiated polycondensation of trichlorotrimethylsilylphosphoranimine (Cl3P=NSiMe3).
This reaction proceeded with trace amounts up to 2 equivalents of PCl5 initiator for every
1 equivalent of Cl3P=NSiMe3, leading to the elimination of trimethylsilyl chloride
(Me3SiCl) as a by-product (Scheme 2.3). The use of trace amounts of PCl5 allowed for
quantitative conversion of the monomer to linear poly[(dichloro)phosphazene], although
preparing reaction mixtures with specified equivalents of initiator to monomer increased
the molecular weight of the resultant poly[(dichloro)phosphazene], with 2 equivalents of
PCl5 to every 1 equivalent of Cl3P=NSiMe3 producing the highest molecular weight
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product. In bulk phase preparation, freshly distilled Cl3P=NSiMe3 and trace PCl5 were
reacted via a heterogeneous reaction in an evacuated, heat-sealed Pyrex tube, similar to
those used for the bulk phase thermal ring opening polymerizations previously discussed,
at room temperature over 24 hours.70 Molecular weight control proved challenging in
bulk phase polymerization, even as the ratio of initiator to monomer was varied, leading
the researchers to look into solution phase polycondensation polymerization. In solution
phase preparation, PCl5 was added to a solution of Cl3P=NSiMe3 dissolved in
dichloromethane (DCM) under nitrogen. The mixture was stirred and allowed to react
for 24 hours at 25°C.

The proposed reaction mechanism of the “living” cationic

polymerization is presented in Scheme 2.4. The polycondensation reaction described
above has also been studied in numerous other solvents to determine solvent effects and
reaction kinetics.72,

73

Although the reaction times of the polycondensation of

Cl3P=NSiMe3 are much less than those used in bulk thermal ring-opening
polymerizations, they require the use of PCl5 which is a highly moisture sensitive
compound that reacts violently with water and poses a potential safety concern. Also, the
hydrolysis of PCl5 leads to the formation of hydrogen chloride (HCl), which could cause
problems with cell viability, as in the case of polymers that hydrolyze into acidic byproducts, if the starting material is not reacted completely and remains in the product due
to insufficient purification.81
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Scheme 2.3: Reaction scheme for the phosphorus pentachloride (PCl5) initiated bulk
and solution phase polycondensation of trichlorotrimethylsilylphosphoranimine
(Cl3P=NSiMe3) to poly[(dichloro)phosphazene] ([NPCl2]n) – The “Living” Cationic
Polymerization Method.
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Scheme 2.4: Proposed cationic polymerization step-wise mechanism of the PCl5
initiated polycondensation reaction of Cl3P=NSiMe3 to [N=PCl2]n.
2.3.1.4

One-Pot De Jaeger Polymerization

In the early 1980s, De Jaeger and co-workers79,
poly[(dichloro)phosphazene]

([NPCl2]n)

80

using

developed an alternative route to
trichloro-N-(dichlorophosphoryl)-

monophosphazene (Cl3P=NP(O)Cl), rather than the standard thermal ring opening
polymerization.

In their synthesis, Cl3P=NP(O)Cl monomer is reacted in the bulk

through a thermal polycondensation reaction that releases P(O)Cl3 (Scheme 2.5). This
reaction is performed in a three-neck reaction vessel with a dry nitrogen gas inlet,
motorized stirring, and two condensers (one with oil cooling at 130°C and the other with
traditional water cooling). The monomer was added to the vessel at 245°C and allowed
to react for approximately 18 hours, at which point trichlorobiphenyl was added as a
solvent to decrease the viscosity of the reaction mixture and improve the conversion of
the monomer to poly[(dichloro)phosphazene]. The reaction mixture dissolved in
trichlorobiphenyl was allowed to react for up to another 34 hours at 276°C. It is not well
documented how the poly[(dichloro)phosphazene] polymer is collected from the reaction
solution, although it is presumed that the solution was concentrated under reduced
pressure and the polymer was reprecipitated with a miscible non-solvent. This method
gives

almost

quantitative

conversion

of

the

monomer

to

linear

poly[(dichloro)phosphazene] and an easily removable P(O)Cl3 byproduct. Drawbacks of
this reaction are the requirement to synthesize the monomer prior to its use in the
polycondensation, which is time consuming and synthetically demanding. The monomer
must also be extremely pure to ensure that the polymerization is successful. Furthermore,
the addition of the trichlorobiphenyl solvent is not ideal for the development of
biomaterials as it is highly toxic and may cause organ damage, and therefore if any
remains in the material following purification it is likely to be cytotoxic.

Another

deterrent from using trichlorobiphenyl solvent is that it is extremely expensive, which is
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not ideal if the ultimate intention is for these materials to be scaled-up for use in the
development of clinically viable tissue-engineered grafts.
O
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Scheme 2.5: Reaction scheme for the synthesis of poly[(dichloro)phosphazene] from
the polycondensation reaction of Cl3P=NP(O)Cl2 – The De Jaeger Method.
Overall, the thermal ring opening polymerization involves the least synthetic chemistry
and has the fewest by-products and potential solvent contaminants, which is ideal for
materials intended for biomedical applications. Therefore, a facile thermal ring opening
polymerization that does not require expensive equipment like rocking machinery within
the oven or the use of a glovebox would be ideal in synthesizing polyphosphazenes for
biomedical applications such as tissue engineering.
2.3.2

Macromolecular Substitution of Poly[(dichloro)phosphazene] with Organic
Nucleophiles

Once high molecular weight linear poly[(dichloro)phosphazene] is synthesized, the
polymer can be modified by substituting the phosphorus-bound chlorine atoms with
organic side groups. The polymer undergoes a macromolecular substitution (Scheme
2.1, reaction of compound 1b into four potential polyphosphazene structures) when
subjected to organic and organometallic nucleophiles, forming a large class of
polyphosphazenes as shown in Figure 2.2.66,

67

All of the polyphosphazenes shown in

Figure 2.2 have one type of side chain throughout the entire polymer, although it has
been shown that developing co-substituted materials with well-defined ratios of side
chains are possible by controlling the amount and order of addition of the nucleophiles.67,
68, 82

The modification of type and ratio of the side chains of the polymer affords the

ability to fine-tune degradation rates and physical properties based on these substituents,
which is key to the synthesis of a biomaterial suitable for tissue engineering and
therapeutic delivery.83
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The main substitution method for amino acid esters that has been described in the
literature entails a two-step reaction in which the free base of the amino acid is generated
prior to substitution by reacting the amino acid ester hydrochloride salt with a nonnucleophilic base, typically triethylamine (TEA, NEt3).12, 15, 55, 67, 83-94 Harry Allcock and
co-workers, the largest players in the field of poly(organophosphazene)s, developed this
method in the 1970s, and have been using it ever since.95 In their synthetic scheme, the
amino acid ester hydrochloride salt is suspended in anhydrous tetrahydrofuran (THF, b.p.
66°C) with an excess of TEA and allowed to reflux with stirring for 24 hours. The
reaction mixture is then filtered and the filtrate is added to a flask containing
poly[(dichloro)phosphazene] dissolved in anhydrous THF. This mixture is allowed to stir
for an additional 48 hours at room temperature until complete substitution has been
achieved.

When preparing co-substituted poly[(amino acid ester)phosphazene]s, the

same general procedure is followed to initially prepare the free bases of the amino acid
esters although the substitution reaction is somewhat modified. In that case, the more
bulky substituent is added first in stoichiometric amounts and allowed to react for a given
time,

based

on

the

reactivity

of

the

specific

substituent,

with

the

poly[(dichloro)phosphazene] precursor.83 Next, the second substituent is added in excess
to react at the remaining P-Cl bonds until the polymer is fully substituted.

After

substitution of either the mono-substituted polyphosphazene or co-substituted
polyphosphazene is complete, the product is precipitated from the THF reaction solution
using anhydrous hexanes. This process is repeated two additional times to remove the
by-products and excess starting materials. The polymer is then occasionally purified
further using cellulose membranes of specific molecular weight cutoffs. All of the
aforementioned reactions and purification procedures are performed under moisture free
conditions in either a glovebox or under dry nitrogen gas using standard Schlenk line
techniques.

Considering the requirement of advanced equipment, like a glovebox,

making the polymers in this fashion is limited to researchers with access to these
expensive pieces, which are not always available or are out of the budget, thus limiting
research into novel polyphosphazene materials, which are suitable for biomedical
applications, to research groups with access to this equipment and hindering the progress
of the field as a whole.
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Along with the reflux and room temperature mixing two-step substitution reaction
described above, Allcock and co-workers also investigated the success of a two-step
reaction at low temperatures as well.95 In the low temperature synthetic scheme, the
amino acid ester hydrochloride salt was reacted with excess triethylamine in refluxing dry
benzene for 3.5 hours, at which point it was cooled and filtered. In a separate flask,
poly[(dichloro)phosphazene] was dissolved in dry benzene and cooled to 0°C. The
filtrate containing the free base of the amino acid ester was then added to this mixture
drop-wise and the solution was allowed to stir for an additional 6 hours at 0°C, followed
by 10 hours at room temperature. The final solution was filtered to remove insoluble
salts and the solution was concentrated by rotary evaporation. The substituted polymer
was collected as a solid by precipitation with n-heptane. This process of dissolution in
benzene and repricipitation in n-heptane was performed twice more to satisfactorily
purify the polymer. Another low temperature substitution method was studied by
Parnigotto and co-workers,77, 78 which used THF as the solvent rather than carcinogenic
benzene and was successful in the synthesis of poly[(amino acid ester)phosphazene]s. An
adapted two-step low temperature substitution was attempted in this work based on the
low temperature variations reported in the literature.

2.4

Suitability of Polyphosphazene Biomaterials

In order for polyphosphazenes to be considered a suitable biomaterial they must be
compatible with the biological environment they are intended to interact with.2, 15, 96 They
must also be either biostable or biodegradable into non-toxic degradation products.
Bioerodible biomaterials are usually preferred since they leave only the natural tissue
once the material has degraded, eliminating the long-term risk of immune response and
potential negative outcomes.2, 5, 13, 83-85, 88, 91, 93, 97-101 Lastly, the biomaterial must have
mechanical properties that match or closely resemble those of the natural tissue so that
issues such as compliance mismatch, a common problem, for example, in vascular tissue
engineering, are reduced.96,
regarding

the

102

In the next few sections, the current understanding

biocompatibility, biodegradation, and mechanical

properties

of

polyphosphazenes biomaterials is summarized. This section will focus on the suitability
of polyphosphazenes, mainly poly[(amino acid ester)phosphazene]s, as biomaterials due
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to their unique tunability of degradation and mechanical properties and non-toxic
degradation products, making them useful in a wide range of biomedical applications
including tissue engineering.12, 15, 68
2.4.1

In Vitro and In Vivo Biocompatibility

The cytocompatibility of amino acid ester functionalized polyphosphazene biomaterials
was first studied by Laurencin et al.88 who compared rat primary osteoblast adhesion to
poly[(ethyl glycinato)phosphazene] (PNEG) with well-known poly(lactic acid-coglycolic acid) (PLAGA) and poly(anhydrides).

Data from this study showed that the

osteoblast cells adhered to the PNEG material to the same extent as the control materials
for a period of 8 hours. The degradation of PNEG did not influence cell proliferation as it
promoted cell growth to the same extent as the PLAGA control material. In a follow-up
study89, similar experiments on other ethyl glycinato/methyl phenoxy co-substituted
polyphosphazenes using MC3T3-E1 cells (osteoblast precursor cell line from mice) were
conducted. The results from this study also suggested that cells responded favourably to
polyphosphazene materials, especially those with a high ratio of ethyl glycinato
substituents, and that cell adhesion and proliferation characteristics were not diminished
in comparison to tissue culture plate and PLAGA controls. The polymers with 50% and
greater of ethyl glycinato substituents demonstrated improved cell growth in comparison
to the tissue culture plate and the polymer with 25% ethyl glycinato substitution was only
slightly less efficient than the tissue culture plate, although all of these were better than
the PLAGA control, which has been widely accepted as a biocompatible material.
Studies on co-substituted amino acid ester based polyphosphazenes containing an ethyl
alanato substituent along with aryloxy substituents such as poly[(ethyl alanato)1(ethyl
oxybenzoate)1

phosphazene]

(PNEAEOB)

and

poly[(ethyl

oxybenzoate)1phosphazene] (PNEAPOB) demonstrated that

alanato)1(propyl

neither PNEAEOB nor

PNEAPOB posed a threat to cell growth, in comparison to the controls, as both materials
were capable of promoting cell adhesion and proliferation.93 Collectively, the results of
the above studies from the Laurencin laboratory are promising since cell adhesion and
proliferation are not affected in comparison to materials that have previously been
extensively studied for their effect on cell viability.
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Gumusderelioglu and Gur103 performed a study that investigated the cytotoxicity of
poly[bis(ethyl-4-aminobutyro)phosphazene] by analyzing the activity level of succinic
dehydrogenase (SDH) through an MTT assay method. SDH plays a critical role in
cellular metabolism and is therefore a good indicator of cytotoxicity.104 For these
experiments extracts collected from the incubation of the polymeric films with growth
medium were added to 3T3 and HepG2 cells. For the negative control, extracts were
collected from a polyethylene centrifuge tube that was incubated with the growth medium
but lacked a sample of polymeric film.

It was shown that poly[bis(ethyl-4-

aminobutyro)phosphazene] extracts did not significantly decrease cell viability in Swiss
3T3 and HepG2 cells in comparison to negative controls. The material maintained cell
viability, as demonstrated by SDH activity level, greater than 80% of that of the control
for all time points and for both cell types. This study was successful in showing the
cytocompatibility of the material with respect to 3T3 and HepG2 cells, which are
commonly used cell lines to study fibroblast and hepatocyte biology, respectively. The
cytocompatibility

of

electrospun

matrices

of

co-substituted

poly[(amino

acid

ester)phosphazene]s towards rat endothelial cells was investigated by Carampin and coworkers.105 They studied poly[(ethyl phenylalanato)1.4(ethyl glycinato)0.6phosphazene]
for both cell adhesion and growth properties in comparison to a fibronectin-coated
polystyrene tissue culture plate as the control. They found that the polymer only slightly
improved cell adhesion (7% increase) in comparison to the culture plates, but that the
polymer enhanced growth of the adhered cells by approximately 17%. These results
reinforced the notion that polyphosphazenes could act as a biocompatible material for use
in biomedical applications such as tissue engineering.
All of the aforementioned studies involved only in vitro analyses of the cytocompatibility
of the polyphosphazenes despite the fact that their end goal is to be used as a biomaterial
in vivo. Towards this end, in vivo studies of alanine-modified polyphosphazenes on rat
and rabbit models for bone tissue engineering materials have been reported.15, 93 In the rat
model93, subcutaneously implanted samples were monitored for biocompatibility through
immune response. Inflammatory responses were categorized as minimal, mild, or
moderate based on the accumulation of immune response cells (e.g. neutrophils/PMNs
and lymphocytes) at the implantation site. It was observed that at two weeks post

23

implantation,

[poly(ethyl

alanato)phosphazene]

(PNEA)

induced

a

moderate

inflammatory response that initially decreased to minimal at four weeks but then slightly
increased

to

mild

at

12

weeks.

As

for

poly[(ethyl

alanato)1(p-methyl

phenoxy)1phosphazene] (PNEAmPh), the material caused a moderate inflammatory
response at two weeks, which gradually decreased to a minimal response after 12 weeks.
The poly[(ethyl alanato)1(p-phenyl phenoxy)1phosphazene] (PNEAPhPh) material
elicited a mild initial response at two weeks, which slowly decreased to a minimal
response at 12 weeks. Overall, the inflammatory responses for the PNEAmPh and
PNEAPhPh were minimal suggesting that the materials are suitable for bone tissue
engineering. The PNEA material triggered a greater inflammatory response than the two
co-substituted polyphosphazenes although the response decreased over the time span of
the study suggesting that, it too, is a good candidate. All three materials elicited immune
responses that were acute and did not pose a long-term threat to the animals.
The potential utility of polyphosphazenes is not limited to bone tissue engineering.
Langone et al.106 conducted in vivo biocompatibility of polyphosphazenes as tubular
nerve guides in rat models. Comparative studies of poly[(ethyl alanato)1.4(imidazolyl)0.6
phosphazene] (PNEAIL) nerve guides with traditional biostable silicone guides suggested
the absence of inflammatory response to the polyphosphazene material after 30 and 60
days of implantation. Upon removal of the implanted nerve guide, it was noted that the
stumps of the rat sciatic nerve, which had initially been transected, had reattached with
components comprised primarily of nerve fiber bundles, akin the natural nerve tissue.
This in vivo study suggested that PNEAIL was a biocompatible material, especially for
use in nerve regeneration strategies, and highlights its potential utility in the future.
2.4.2

Biodegradability

Since it is desirable to use biodegradable biomaterials for tissue engineering and delivery
of therapeutics many research groups have studied the degradation properties of
polyphosphazenes.13, 84, 85, 91, 93, 97, 98, 100, 101, 107 Polyphosphazenes are attractive because
they have been shown to degrade into non-toxic by-products that are easily metabolized
by the body.

In the case of an amino acid ester phosphazene, these hydrolytic

degradation products include the amino acid, the corresponding alcohol of the ester,
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ammonia, and phosphates.84 Unlike the acidic products produced from the hydrolysis of
other polymers, the ammonia and phosphates act as a buffering system and prevent
fluctuations in pH, which could otherwise be detrimental to the tissue.108 Although the
exact mechanism of degradation is not known, there are several pathways that have been
proposed.84 Overall, the first two steps of the degradation result in the hydrolysis of the
ester of the amino acid, forming an alcohol, and detachment of the amino acid from the
polyphosphazene backbone forming the amino acid itself.

The backbone of the

polyphosphazene is then hydrolyzed to phosphates and ammonia. The formation of
phosphates during the degradation process was verified through the addition of silver
nitrate or zirconyl chloride, which forms a yellow silver phosphate or white zirconyl
phosphate precipitate, respectively.84 The amino acids and ammonia degradation products
can be demonstrated by ninhydrin test, which detects ammonia, primary, and secondary
amines, whereas as 1H nuclear magnetic resonance (NMR) spectroscopy can be utilized
for detecting alcohols.
Another important factor with regards to biodegradability is the rate at which the material
degrades since this can limit potential applications. It is important when designing a
scaffold that the material degrades at a rate that is similar to the rate of tissue growth or
therapeutic release rate depending on the application. For tissue engineering, if the
scaffold material degrades too quickly there will be insufficient support for the
underdeveloped tissue and mechanical weakness will ensue. If the material degrades too
slowly or not at all, it may need to be surgically removed, which could in turn damage the
neo-tissue and cause problems with mismatched mechanical properties relative to the
natural tissue.35 In order to determine the degradation rates of poly[(amino acid
ester)phosphazene]s, the influence of changing the types and ratios of side chain
substituents on the degradation properties of the polymers is an important factor. Table
2.1 provides an overview of the degradation studies that have been performed on
polyphosphazenes substituted with amino acid esters and other co-substituents.
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Table 2.1: Summary of in vitro degradation studies of poly[(amino acid
ester)phosphazene]s and their co-substituted polyphosphazenes. The ester refers to
the chain attached to the carboxyl terminus of the amino acid. The detailed
degradation profiles can be found in the cited references.

In view of this, the degradation rates of poly[(amino acid ester)phosphazene]s with
different amino acids and different esters of the amino acids were studied in solution- and
solid-state, although solid-state degradation is more representative of how degradation
would occur with in vivo scaffold materials and is the method that will be discussed.84
The effect of changing the ester group was investigated using glycine based poly[(amino
acid

ester)phosphazene]s

(PNMG),

poly[bis(ethyl

including

poly[bis(methyl

glycinat-N-yl)phosphazene]

glycinat-N-yl)phosphazene]
(PNEG),

poly[bis(tert-butyl

glycinat-N-yl)phosphazene] (PNtBG), and poly[bis(benzyl glycinat-N-yl)phosphazene]
(PNBzG). In this systematic study, the molecular weight decline was in the order of
PNBzG < PNtBG < PNEG < PNMG, with PNMG having the greatest decrease in
molecular weight. This showed that as the hydrophobicity of the ester group increased
(from methyl to benzyl), the molecular weight decline of the polymer decreased. The
decreased molecular weight decline is due to the inability of water to approach the
polymer due to its hydrophobicity, and therefore the hydrolysis of the material is
hindered. The effect of changing the amino acid using poly[bis(methyl glycinat-Nyl)phosphazene]
poly[bis(methyl

(PNMG),

poly[bis(methyl

valinat-N-yl)phosphazene]

alaninat-N-yl)phosphazene]
(PNMV),

and

(PNMA),

poly[bis(methyl

phenylalaninat-N-yl)phosphazene] (PNMF) showed that the molecular weight decline
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increased on the order of PNMF < PNMV < PNMA < PNMG. This trend was observed
since the hydrophobicity of the polymer increased as larger non-polar side chain amino
acids, like phenylalanine, were incorporated into the polyphosphazene. This study was a
good initial demonstration of the biodegradability and hydrolysis properties of different
poly[(amino acid ester)phosphazene]s, although a more suitable degradation medium
would be phosphate buffer solution (PBS) at 37°C, which is more representative of the
body fluid pH, temperature, and ion concentrations.
The effect that types of side groups had on the degradation rates of L-alanine cosubstituted

polyphosphazenes,

specifically

PNEA,

poly[(ethyl

alanato)1(ethyl

glycinato)1phosphazene] (PNEAEG), PNEAmPh, and PNEAPhPh was also reported in a
separate study.83 As may be expected the ethyl glycinato substituted phosphazene
(PNEAEG) had the fastest molecular weight decline, where as the biphenyl substituted
phosphazene (PNEAPhPh) had the slowest molecular weight decline. The PNEAEG
material hydrolyzed so quickly that molecular weight could not be evaluated beyond
week two of the degradation study. It was noted that the pattern of molecular weight
decline showed a quicker degradation rate for the smaller, more hydrophilic substituent
polymers as compared to those substituted with large bulky hydrophobic substituents.
Compared to imidazolyl side groups, increasing the amount of ethyl glycinato groups
increased the degradation rate of the polymer, indicating that the incorporation of less
sterically hindered, more hydrophilic groups causes the polymers to degrade more
quickly.89 The results of the study were successful in demonstrating the tunability of
degradation properties of co-substituted polyphosphazenes, which is a key requirement in
the development of a biomaterial for tissue engineering applications. Overall, this study
effectively showed the ability to tune degradation rates of poly[(amino acid
ester)phosphazene]s through careful selection of side group substituents. In vivo
degradation studies showed substantial decline in molecular weight for the PNEA and
PNEAmPh implants after 12 weeks, 80% and 98%, respectively.93 PNEAPhPh, on the
other hand, did not experience as great of a molecular weight decline as the other two
implants and had a molecular weight decline of only 63% after 12 weeks. This is
presumably due to the increased hydrophobicity of the biphenyl substituent, which limits
the approach of water to the polymer backbone and therefore slows its hydrolysis. This
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study proves the in vivo biodegradability of poly[(amino acid ester)phosphazene]s, as
well as their biocompatibility. The results of this study should be taken with caution
since the implant in this cited study was designed for bone tissue engineering applications
and as such, it is implanted into a region of the rat where bone tissue is the predominant
tissue type.

Naturally occurring enzymes, which have the potential to significantly

influence degradation rates if they recognize the materials, have different abundances
across different types of tissues. Therefore, if the poly[(amino acid ester)phosphazene]s
investigated in this study are to be applied to other tissue engineering applications, such
as vascular tissue engineering, their degradation rates in those tissues may vary
dramatically from those presented here due to differences in enzymatic degradation. The
relative abundance of water in a tissue also determines rates of hydrolysis and the
materials could therefore show significantly different hydrolytic degradation rates in
different tissues.
Other studies were conducted on the effects of changing ratios of substituents on the
degradation rates of the polymers.99 Mass loss measurements following PBS incubation
focused on co-substituted polyphosphazenes of ethyl 2-(O-glycyl)lactate and ethyl
glycinate. Decreasing the ratio of ethyl glycinate: ethyl 2-(O-glycyl)lactate, for materials
with varying side chain ratios between 100% ethyl glycinate: 0% ethyl 2-(Oglycyl)lactate to 75% ethyl glycinate: 25% ethyl 2-(O-glycyl)lactate, increased the mass
loss rate of the polymer. This is due to the increased hydrolytic sensitivity of ethyl 2-(Oglycyl)lactate, in comparison to ethyl glycinate, which encourages polymer degradation
and therefore mass loss as well. Even though mass loss is not a direct indication of
molecular weight decline83, it is still a good indicator of the relative degradation rates of
the polymers and as such, it can be approximated that polymers with a higher ratio of
ethyl glycinato substitution degrade less quickly than those with increased levels of ethyl
2-(O-glycyl)lactate. This study was useful in demonstrating the effect that varying ratios
of substituents with different hydrolysis-sensitivities and solvation properties has on the
degradation rates of the polymers, which can be useful for tailoring degradation
properties of co-substituted polyphosphazenes according to their specific biomedical
applications.
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Taken together, these studies have been able to demonstrate not only that poly[(amino
acid ester)phosphazene]s are biodegradable, but also that their degradation rates can be
tuned by changing a variety of factors, such as type and ratio of side groups. The fact that
bioerodability studies have been performed in vitro in body fluid simulating solutions and
in vivo in rat models suggests that these polyphosphazene materials are suitable for use in
tissue engineering applications such as scaffold biomaterials as well as for other
biomedical applications that require the use of degradable materials.
2.4.3

Mechanical Properties

In order to produce clinically viable tissue engineered products, the mechanical properties
of the constructs must match the properties of the natural tissues. If the mechanical
properties, such as compressive strength and tensile strength, are not comparable to those
of native tissues, problems with mismatch arise which often lead to failure of the tissueengineered construct.109-112 There have been only a limited number of studies carried out
to investigate the mechanical properties of poly[(amino acid ester)phosphazene]
materials. One such study was conducted by Sethuraman et al.94 who investigated the
mechanical properties of alanine-based polyphosphazenes for their application as bone
tissue engineering biomaterials. For these studies polyphosphazenes were compared with
the current standard for bone tissue engineering applications, PLAGA (85% lactic
acid:15% glycolic acid). Cylindrical discs of each polymer were initially subjected to a
compressive force of 1500 pounds per square inch (psi) for 15 min and analyzed using a
uniaxial compressive testing instrument set with the following parameters, 500N load cell
and 10 mm/min compression rate, until material failure. The compressive strengths of
PNEA and PNEAmPh were comparable to that of PLAGA (34.9 ± 5.7 MPa), with
compressive strengths of 46.61 ± 17.56 MPa and 24.98 ± 11.26 MPa, respectively.
PNEAPhPh on the other hand had a compressive strength that was significantly higher
than that of PLAGA due to the large aromatic groups increasing steric bulk and
decreasing torsion of the polymer backbone. Together these increase the rigidity of the
material and modulate its compressive properties. Therefore, it can be noted that the
mechanical properties, like the degradation properties, of polyphosphazene materials can
be tailored based on their proposed applications by changing the side group substituents.
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The tensile strength and elasticity of several L-alanine based polyphosphazene materials
(namely, PNEAEG, PNEA, PNEAmPh, and PNEAPhPh) were determined using microtensile testing techniques.94 It was shown that increasing the steric bulk of the cosubstituent increased both the tensile strength and elasticity of the material with more of
an impact being observed as the side chain is changed from a small amino acid such as
glycine or alanine ethyl ester, such as in PNEAEG and PNEA, to large aromatic
substituents, such as in PNEAmPh and PNEAPhPh. This is because introducing large
aryloxy substituents affects the glass transition temperature and molecular weight of the
polymer, which in turn affects the mechanical properties of the material. Overall, this
study shows how the mechanical properties of a polyphosphazene material can be
tailored simply through co-substitution of large aromatic groups alongside amino acid
esters.
Both of the above studies showed that changing the types and ratios of side group
chemistries of polyphosphazene materials can modulate mechanical properties, such as
compressive strength, tensile strength, and elasticity. Therefore, the mechanical
properties of these materials can be tuned to suit the intended application, making
polyphosphazenes useful as biomaterials in a wide range of different biomedical
applications.

One concern here is that changing the side groups not only affects

mechanical properties but also degradation rates and therefore adapting the side chains to
obtain suitable mechanical properties may cause the degradation rate of the material to be
either too fast or too slow for the application, which is undesirable. As such, it is
suggested that research into other methods to control mechanical properties that do not
influence erosion properties should be developed. For example, it may be useful to
investigate the effects of different processing methods or scaffold preparation techniques
(e.g. electrospinning versus solvent casting and particulate leaching) on mechanical
properties.

2.5

Objectives and Rationale

As was shown in the preceding literature review, poly(organophosphazene)s have been
studied extensively for their use in many biomedical applications, including tissue
engineering.

To date, the majority of research surrounding poly[(amino acid
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ester)phosphazene]s focuses on orthopedic tissue engineering and drug delivery
applications with limited use in vascular tissue engineering.87-89,

93, 94, 113

A potential

reason as to why these materials have been limited to mainly bone applications is that the
synthesis of the precursor material (poly[(dichloro)phosphazene]) requires either
extensive chemical synthesis and/or expensive specialized equipment before the actual
poly[(amino acid ester)phosphazene] materials can be realized. By optimizing a thermal
ring opening synthesis process that requires less harsh reaction conditions and fewer
costly pieces of machinery, thus making it more accessible to researchers like ourselves,
poly[(amino acid ester)phosphazene]s may be investigated for other biomedical
applications, including vascular tissue engineering. It is also hoped that the substitution
of poly[(dichloro)phosphazene] with organic nucleophiles can be simplified into a onepot reaction and eliminate the necessity of liberating the free base of the amino acid ester
at elevated temperatures prior to reaction. Once these two techniques are developed, it is
proposed that they will be used to synthesize novel co-substituted poly[(amino acid
ester)phosphazene]s that incorporate amino acids that have functional side chains (e.g.
glutamic acid, aspartic acid, and lysine) and can be used for further surface modification
of the materials.

The functional handles that will be made available through the

deprotection of the side chains will allow for the conjugation of biomolecules that are
known to enhance cell-material interactions, which is ideal in developing biomaterials for
scaffolds. Lastly, considering that scaffolds are required to have a 3-D configuration for
vascular graft formation, electrospinning of the poly[(amino acid ester)phosphazene]s
should be investigated.
In view of the above rationale, the objectives of this work were to:


Develop a facile polymerization technique and compare substitution methods for
the synthesis of poly(amino acid ester)phosphazenes



Prepare the benzyl side chain protected glutamic acid ethyl ester via esterification
and deprotection



Synthesize and characterize (FTIR, NMR, TGA, DSC, and GPC) a family of nonfunctional and functional poly[(amino acid ester)phosphazene]s
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o Non-functional

amino

acid

ethyl

esters:

alanine,

phenylalanine,

methionine
o Functional amino acid ester: benzyl side chain protected glutamic acid
ethyl ester


Evaluate cytotoxicity of functional and non-functional poly[(amino acid
ester)phosphazene]s on 2-D films



Fabricate

a

electrospinning

polyphosphazene-based

3-D

non-woven

fibrous

mat

via
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Chapter 3
3
3.1
3.1.1

Materials and Methods
Thermal Ring Opening Polymerization (TROP)
Materials

The hexachlorocyclotriphosphazene cyclic trimer was purchased from Sigma Aldrich
(Milwaukee, WI) and Alfa Aesar (Ward Hill, MA). Anhydrous tetrahydrofuran (THF),
glass distilled hexanes-190, 2-propanol (iPrOH), reagent grade hydrochloric acid (HCl),
and potassium hydroxide (KOH) were obtained from Caledon Labs (Georgetown, ON).
Krytox Performance Lubricant GPL207 high temperature grease was acquired from
DuPont (Wilmington, DE). All chemicals and solvents were used as received without
further purification.
3.1.2

Equipment

The polymerizations were performed in a VWR Symphony Horizontal Air Flow Oven
(50L, 1.75cuft, 120V, 60Hz) purchased from VWR International (Radnor, PA). The glass
reaction vessels and stainless steel vial rack shown in Figure 3.1 were manufactured by
the glass blowing and engineering machine shops at The University of Western Ontario
(London, ON), respectively.
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Figure 3.1: The glass vials and stainless steel vial rack that were manufactured inhouse for the facile thermal ring opening polymerizations. The schematic on the
right side shows approximately dimensions of the glass vials and stoppers used as
the reaction vessels.
3.1.3

Method

The polymerizations were performed in batches of three reaction vessels, with each
reaction

vessel

containing

approximately

1.06g

(3.05mmol,

1.0

equiv)

of

hexachlorocyclotriphosphazene. The vessels were prepared by weighing the trimer into
the glass vial, lubricating the glass stopper with sufficient Krytox grease, and sealing the
vial with the glass stopper. The vessels were then placed in a line in the vial rack and the
rack was inserted into the preheated high temperature oven set at 230 °C with the vessels
spanning from left to right in the oven and the rack being positioned approximately in the
center of the oven. The optimized reaction scheme for the ring opening polymerization is
presented in Scheme 3.1. A programmable timer on the oven was used to control the
length of the reaction, where the oven would stop heating and would cool to room
temperature after the specified time. It took approximately 6 minutes for the oven to cool
to temperatures below 200 °C, which was likely too cool for polymerization to occur.
Once the oven had cooled, the samples were removed from the oven and scrapped from
the inside of the vials into a 50mL centrifuge tube, where they were then purified by
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dissolving the product in minimal anhydrous THF and reprecipitating the polymer in
hexanes.

The crude product dissolved in anhydrous THF was filtered to remove

insoluble impurities prior to repricipitation with hexanes. This dissolution/reprecipitation
process was repeated three times. The poly[(dichloro)phosphazene] (PDCP) material is
highly reactive and cannot be dried completely due to its quick decomposition when
overnight drying under vacuum was attempted. This was also presumably due to rapid
hydrolysis of the material upon exposure to even atmospheric moisture and therefore the
material must be used in a substitution reaction immediately after its purification.
Cl

Cl
P

Cl
Cl

N

N

P

P
N

Cl
230oC , 25h
Cl
Cl

hexachlorocyclotriphosphazene
(cyclic trimer)

N

P
Cl

n

polydichlorophosphazene
(linear precursor, PDCP)

Scheme 3.1: Reaction scheme for the facile thermal ring opening polymerization
(TROP) of hexachlorocyclotriphosphazene to linear poly[(dichloro)phosphazene]
(PDCP).
After recovery of the PDCP product and in between polymerizations, the glass reaction
vessels were cleaned using a base bath, water rinse, acid bath, water rinse, and drying
method to remove any residual polymer or grease. The base bath used was a concentrated
solution of KOH in 50/50 mixture of iPrOH and deionized (DI) H2O. The acid bath was
a concentrated solution of HCl in DI water. Typically, the reaction vessels were allowed
to soak in the base bath overnight, were rinsed with DI water, and were scrubbed clean
using a small wire scrub brush. The vessels were then rinsed with more DI H2O and
allowed to soak in the acid bath for a minimum of 2 hours. Upon removal from the acid
bath, the vials were rinsed with DI H2O one final time and were dried in a drying oven
prior to their re-use.
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3.2
3.2.1

Macromolecular Substitution of Non-Functional Amino Acid
Esters
Materials

Anhydrous THF and glass-distilled hexanes were again acquired from Caledon Labs. All
non-functional amino acid esters, L-alanine ethyl ester hydrochloride (H-Ala-OEtHCl),
L-phenylalanine ethyl ester hydrochloride (H-Phe-OEtHCl), and L-methionine ethyl
ester hydrochloride (H-Met-OEtHCl), were from Alfa Aesar (Ward Hill, MA).
Triethylamine

(NEt3)

was

purchased

from

Sigma

Aldrich.

The

poly[(dichloro)phosphazene] (PDCP) material was obtained from the thermal ring
opening polymerization described above.

All chemicals and solvents were used as

received.
3.2.2

Sample Nomenclature

The amino acid ester polyphosphazenes were named systematically as follows PP-A100,
where the PP indicates that the backbone is a polyphosphazene and the A100 represents
100 mole percent (mol %) substitution with L-alanine ethyl ester substituents. In all cases
the amino acid is connected to the phosphorus atoms of the polyphosphazene backbone
through the N terminus amino group. Note that the one-letter abbreviations for alanine,
phenylalanine, methionine, and glutamic acid are A, F, M, and E, respectively, although
through out this work A, F, and M, represent the ethyl esters of the L-amino acids and E*
represents the ethyl ester of L-glutamic acid which has its side chain carboxylic acid
protected with a benzyl group.
3.2.3

Methods

Described in the next three sections are three different substitution methods performed at
different temperatures and with or without the initial reaction to liberate the free base of
the amino acid prior to substitution. These were variations performed to determine their
influence, if any, on the poly[(amino acid ester)phosphazene] products.
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3.2.3.1

Low Temperature Two-Step Reaction (LT 2S)

H-Ala-OEtHCl (1.70g, 11.1mmol, 2.6 equiv) was added to 10mL of THF and mixed
with an excess (x.s.) of NEt3 (2.0mL, 1.5g, 14mmol, 3.3 equiv) for 1 hour at room
temperature in a rubber septum sealed round bottom flask (Scheme 3.2, Mixture A). In
a separate flask, PDCP (0.50g, 4.3mmol of NPCl2 units, 1.0 equiv) recovered from the
thermal ring opening polymerization step was dissolved in 5mL of THF. Mixture A was
cooled in an ice bath to 0°C and the PDCP solution was added drop-wise through the
rubber septum over a time span of 1 hour (Mixture B). Mixture B was then allowed to
stir at room temperature for 48 hours after which the solution was filtered and the product
was collected by repricipitation in hexanes. The product was purified by dissolving the
polymer in anhydrous THF and reprecipitating in hexanes 3 times. The collected product
was dried under vacuum at room temperature overnight. Percent yield was determined
based on the approximate weight of PDCP. This technique slightly underestimates the
yield collected as the PDCP is incapable of being dried completely and therefore the
initial mass of PDCP added also includes the mass of residual solvents (THF and
hexanes) from its purification after the thermal ring opening polymerization. Scheme 3.2
below shows the overall synthetic scheme and the chemical structures of the starting
materials and polyphosphazene product.
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Scheme 3.2: Reaction scheme for the low-temperature macromolecular substitution
of L-alanine ethyl ester with poly[(dichloro)phosphazene] (PDCP) forming
poly[bis(ethyl alanato)phosphazene] (PP-A100).
This method was also utilized in the synthesis of L-phenylalanine ethyl ester (PP-F100)
and L-methionine ethyl ester (PP-M100) polyphosphazene materials (Figure 3.2),
substituting H-Phe-OEtHCl and H-Met-OEtHCl for H-Ala-OEtHCl, respectively.
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Figure 3.2: Chemical structures of the L-phenylalanine ethyl ester (PP-F100) and Lmethionine ethyl ester (PP-M100) based polyphosphazene materials.
3.2.3.2

One-Pot Room Temperature Reaction (1P RT)

In an effort to simplify the substitution process the amino acid ester hydrochloride salt,
triethylamine and poly[(dichloro)phosphazene] were all added to the reaction flask at the
same time and allowed to stir for 72 hours at room temperature. H-Ala-OEtHCl (1.70g,
10.4mmol, 2.6 equiv) was initially added to 10mL of anhydrous THF and sealed with a
rubber septum. In a separate flask, poly[(dichloro)phosphazene] (0.50g, 4.3mmol of
NPCl2 units, 1.0 equiv) collected from the thermal ring opening polymerization was
dissolved in 10mL of THF. Next, triethylamine (2.0mL, 1.5g, 14mmol, 3.3 equiv) and
the PDCP solution were both added through the septum into the reaction flask containing
the amino acid ester and THF solution. This mixture was stirred at room temperature for
72 hours (Scheme 3.3). The polyphosphazene product was purified in the same manner
as the LT 2S method discussed above.
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Scheme 3.3: Reaction scheme for the one-pot room temperature synthesis of
poly[bis(ethyl alanato)phosphazene] (PP-A100) from L-alanine ethyl ester
hydrochloride (H-Ala-OEtHCl) and poly[(dichloro)phosphazene] (PDCP).
As with the LT 2S method, L-phenylalanine ethyl ester and L-methionine ethyl ester
based polyphosphazenes were also synthesized by replacing H-Ala-OEtHCl with HPhe-OEtHCl and H-Met-OEtHCl, respectively (Figure 3.2).
3.2.3.3

Room Temperature Two-Step Reaction (RT 2S)

The last reaction method similar to the widely used macromolecular substitution
technique found in the literature, which involves refluxing the amino acid ester
hydrochloride salt with triethylamine to liberate the free base of the amino acid ester prior
to its addition to poly[(dichloro)phosphazene]. H-Ala-OEtHCl (1.70g, 10.4mmol, 2.6
equiv) was added to a round bottom flask with 2mL of NEt3 (1.5g, 14mmol, 3.3 equiv)
and 10mL of anhydrous THF (BP 66°C). The mixture was refluxed for 24 hours and the
product was filtered. The filtrate containing the free base of the amino acid ester was
collected and added to another round bottom flask containing 0.50g of PDCP (4.3mmol
of NPCl2 units, 1.0 equiv) dissolved in 10mL of THF. This mixture was allowed to stir
for 48 hours at room temperature (Scheme 3.4). The resulting polyphosphazene material
was collected and purified using the same techniques used in the LT 2S and 1P RT
methods.
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Scheme 3.4: Reaction scheme for the room temperature two-step substitution of
poly[(dichloro)phosphazene] (PDCP) with L-alanine ethyl ester (H-Ala-OEtHCl).
The L-phenylalanine ethyl ester (PP-F100) and L-methionine ethyl ester (PP-M100)
polyphosphazene equivalents were made using the same reaction scheme and substituting
H-Ala-OEtHCl for H-Phe-OEtHCl and H-Met-OEtHCl, respectively (Figure 3.2).

3.3
3.3.1

Preparation of Glutamic Acid Ethyl Ester (E*)
Materials

Glass distilled dichloromethane (DCM), ethyl acetate (EtOAc), trifluoroacetic acid
(TFA), sodium bicarbonate (NaHCO3), and anhydrous magnesium sulphate (MgSO4)
were all obtained from Caledon Labs. Anhydrous ethanol (EtOH) was acquired from
Commercial Alcohols Inc. (Brampton, ON). The DCM and EtOH were dried overnight
over molecular sieves, 4Å and 3Å (Caledon Labs), respectively, prior to their use. 4Dimethylaminopyridine (DMAP) and 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide
hydrochloride (EDCI) were purchased from Alfa Aesar. Protected functional amino
acids,

N-α-fluorenylmethyloxycarbonyl-L-glutamic

acid

γ-benzyl

ester

(Fmoc-
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Glu(OBzl)-OH) and N-α-tert-butyloxycarbonyl-L-glutamic acid γ-benzyl ester (BocGlu(OBzl)-OH), were procured from EMD Millipore Corporation (Chicago, IL). All
chemicals and solvents were used as received unless stated otherwise.
3.3.2
Before

Methods
reacting

the

functional

glutamic

acid

ethyl

ester

with

poly[(dichloro)phosphazene], the glutamic acid must first be converted to an ester at the
carboxyl terminus (COOH) and the amino terminus (NH2) must be deprotected to obtain
the free base. See Figure 3.3 for the chemical structures of the Fmoc and Boc protected
glutamic acid starting materials noting that the esterification reaction will modify the
COOH group to an ethyl ester.

O

Benzyl (Bzl) protecting group

O

O
O

N
H

OH
O
Glutamic acid (Glu, E)

O

O

Fmoc protecting group
O
O
Boc protecting group

N
H

OH
O

Figure 3.3: Chemical structures of Fmoc- and Boc-protected glutamic acid that will
be esterified to their ethyl ester amino acid derivatives.
3.3.2.1

Ethyl Esterification of Fmoc-Glu(OBzl)-OH and Boc-Glu(OBzl)-OH

The Fmoc-Glu(OBzl)-OH (1.0g, 2.2mmol, 1.0 equiv) amino acid, EDCI coupling agent
(0.46g, 2.4mmol, 1.1 equiv), and DMAP (0.024g, 0.2mmol, 0.1 equiv) catalyst were
added to a 25mL round bottom flask, evacuated, and placed under inert N2 atmosphere
using a standard Schlenk line. Next, 8mL of dry DCM and 0.15mL of anhydrous EtOH
(0.12g, 2.5mmol, 1.1 equiv) were added to the reaction flask and the mixture was allowed
to stir at 0°C in an ice bath for 3 hours, followed by stirring for another 3 hours at room
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temperature (Scheme 3.5). The mixture was concentrated in vacuo using a rotary
evaporator followed by drying overnight on the in-house vacuum line. The crude product
was weighed and taken up in 20mL of a 50/50 mixture of EtOAc and DI H2O for
purification. The solvent mixture containing the product was washed three times with
15mL of a saturated solution of NaHCO3 in DI H2O and three times with 15mL of pure
DI H2O at 60°C to remove water-soluble impurities. The EtOAc layer was collected and
dried over MgSO4 and concentrated in vacuo. The same procedure was used to prepare
Boc-Glu(OBzl)-OEt by replacing Fmoc-Glu(OBzl)-OH with Boc-Glu(OBzl)-OH.

Scheme 3.5: Expected reaction schemes for the ethyl esterification of FmocGlu(OBzl)-OH and Boc-Glu(OBzl)-OH to Fmoc-Glu(OBzl)-OEt and BocGlu(OBzl)-OEt, respectively, using carbodiimide coupling chemistry.
3.3.2.2

TFA Deprotection of Boc-Glu(OBzl)-OEt

The Boc protecting group was deprotected by dissolving the Boc-Glu(OBzl)-OEt in 1:3
TFA in DCM (Scheme 3.6). The amount of TFA/DCM solution used was based on the
mass of Boc-Glu(OBzl)-OEt to be deprotected with 2mL of 25% TFA in DCM for every
75mg of protected amino acid. The TFA/DCM mixture and the amino acid were allowed
to stir for 2 hours at room temperature and excess TFA was removed by bubbling N2 gas
through the solution for a minimum of 3 hours. Any remaining DCM solvent was
removed in vacuo and the corresponding TFA salt of the deprotected glutamic acid ethyl
ester was collected as a viscous oil.
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Scheme 3.6: Boc deprotection of glutamic acid ethyl ester (Boc-Glu(OBzl)-OEt)
using a 1:3 mixture of trifluoroacetic acid (TFA) in dichloromethane (DCM).

3.4
3.4.1

Macromolecular Co-substitution of Non-Functional Amino Acids
with Functional Glutamic Acid
Materials

Anhydrous tetrahydrofuran (THF) and glass-distilled hexanes-190 were obtained from
Caledon Labs. Triethylamine (NEt3) was purchased from Sigma Aldrich. All nonfunctional amino acid esters, L-alanine ethyl ester hydrochloride (H-Ala-OEtHCl), Lphenylalanine ethyl ester hydrochloride (H-Phe-OEtHCl), and L-methionine ethyl ester
hydrochloride (H-Met-OEtHCl), were from Alfa Aesar. The amine-deprotected glutamic
acid ethyl ester (TFA- NH3+-Glu(OBzl)-OEt) was acquired from the preceding ethyl
esterification and deprotection of Boc-Glu(OBzl)-OH procedures.
3.4.2

Methods

The general procedure for the synthesis of the co-substituted polyphosphazenes with both
non-functional and functional amino acid esters was adapted from the one-pot room
temperature substitution method used for the non-functional amino acids. Rather than
adding the amino acids sequentially, which has been shown to cause very specific
substitution patterns depending on the type of nucleophile, half of the total amount of the
non-functional amino acid ester to be reacted was mixed initially with PDCP. After
sufficient reaction time all of the functional amino acid ester was added to the mixture
and allowed to react for 24 hours. Finally, the remaining amount of non-functional
amino acid ester was added and the complete mixture was allowed to react for an
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additional 48 hours, at which point the reaction solution was filtered and the cosubstituted poly[(amino acid ester)phosphazene] was precipitated from the filtrate with
hexanes. Described here in detail is the synthetic scheme for a co-substituted
polyphosphazene with 90% Ala-OEt and 10% Glu(OBzl)-OEt (PP-A90E*10) substituents
although similar materials containing 90% Phe-OEt/10% Glu(OBzl)-OEt (PP-F90E*10)
and 90%Met-OEt/10%Glu(OBzl)-OEt (PP-M90E*10) were also synthesized (Figure 3.4).
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Figure 3.4: Chemical structures of the co-substituted poly[(amino acid
ester)phosphazene]s based on the non-functional amino acid esters, Ala-OEt, PheOEt, Met-OEt, and side chain protected functional amino acid ester, Glu(OBzl)OEt.
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H-Ala-OEtHCl (0.79g, 5.1mmol, 1.2 equiv) and 5mL of anhydrous THF were added to
a 50mL round bottom flask and mixed at room temperature. Next, 0.9mL of NEt3 (0.65g,
6.4mmol, 1.5 equiv) and a 5mL solution of poly[(dichloro)phosphazene] (0.50g, 4.3mmol
of NPCl2 units, 1.0 equiv) were added to the flask, the flask was sealed and the entire
mixture was allowed to stir for 24 hours at room temperature. After 24 hours, TFANH3+-Glu(OBzl)-OEt (0.32g, 0.86mmol, 0.2 equiv) dissolved in 5mL of THF and 0.2mL
of NEt3 (0.15g, 1.5mmol, 0.3 equiv) and the flask was resealed and allowed to stir for yet
another 24 hours at room temperature. Finally, H-Ala-OEtHCl (0.79g, 5.1mmol, 1.2
equiv), 5mL of anhydrous THF, and 0.9mL of NEt3 (0.65g, 6.4mmol, 1.5 equiv) were
added to the reaction flask and the complete mixture was stirred at room temperature for
an additional 48 hours (Scheme 3.7). Upon completion of the reaction, the mixture was
filtered to remove insoluble impurities and the product was precipitated from the THF
solution using hexanes. Following this, the product was dissolved and precipitated from
THF to hexanes a total of three times to help purify the polymer. Lastly, the polymer was
dried in vacuo overnight on the in-house vacuum line.
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Scheme 3.7: One-pot three-stage room temperature reaction of a co-substituted
poly[(amino acid ester)phosphazene] (PP-A90E*10 shown here) from the functional
amino acid ester (TFA- NH3+-Glu(OBzl)-OEt), non-functional amino acid ester (HAla-OEtHCl) and poly[(dichloro)phosphazene] precursor (PDCP).
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3.5

Conjugation of a Model Compound to the Functional
Polyphosphazenes

In order to impart biological properties, materials are often coated or conjugated with
biomolecules. These biomolecules, such as growth factors and signaling components, are
typically small proteins and including a functional moiety in the biomaterial that can
allow for the attachment of these types of molecules. Here, the pendant side chain
carboxylic acid group of glutamic acid can be used as a site for biomolecule attachment
and therefore its deprotection and reaction with a model compound have been explored as
a proof of concept for attachment of biomolecules in the future.
3.5.1

Materials

The co-substituted functional polyphosphazenes containing glutamic acid side chains
paired with non-functional amino acid side chains (PP-A90E*10, PP-F90E*10, and PPM90E*10) were obtained from the one-pot room temperature substitution method described
above. Anhydrous EtOH was purchased from Commercial Alcohols Inc. The palladium
on carbon (Pd/C) catalyst was purchased from Sigma Aldrich and had a loading of 10 wt.
% on a matrix activated carbon support.
3.5.2
3.5.2.1

Methods
Hydrogenation of Benzyl Protecting Group

Hydrogenation of the benzyl ester protecting groups on the glutamic acid side chains was
performed under a hydrogen atmosphere using a Pd/C catalyst. The PP-A90E*10 (84mg,
0.27mmol of Ala/Glu(OBzl) substituted P=N units, 1.0 equiv) was dissolved in 4.5 mL of
EtOH and the flask was evacuated under reduced pressure. The Pd/C catalyst (6 mg, 7
wt. % of polymer, 5.6μmol of Pd) was added to the reaction flask and the vessel was
purged with H2.

The reaction mixture was allowed to stir for 3.5 hours at room

temperature, at which point the hydrogenation was complete as determined by 1H NMR
spectroscopy (Scheme 3.8), although the reaction also lead to disruption of the
polyphosphazene backbone (see Chapter 4 – Results and Discussion for further
information). The Pd/C catalyst was removed by filtration through celite and the solvent
was removed in vacuo.
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Scheme 3.8: Reaction scheme for the hydrogenation of benzyl ester protecting
groups on glutamic acid in the co-substituted polyphosphazene of L-alanine ethyl
ester (H-Ala-OEt) and benzyl protected L-glutamic acid ethyl ester (H-Glu(OBzl)OEt).

3.6
3.6.1

Material Characterization
Nuclear Magnetic Resonance Spectroscopy (NMR)

Nuclear Magnetic Resonance (NMR) spectroscopy was performed on a Varian INOVA
400 MHz spectrometer (1H 400.1 MHz, and
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P{1H} 161.8 MHz, Varian Canada Inc.,

Mississauga, ON). Chemical shifts are reported in parts per million (ppm) and were
referenced relative to residual solvent signals of chloroform (CDCl3, δ 7.27 ppm) for all
non-functional amino acid ester hydrochloride salts (H-Ala-OEtHCl and H-MetOEtHCl), Fmoc- and Boc-Glu(OBzl)-OH including products relating to the their
esterification and deprotection, and all poly[(amino acid ester)phosphazene]s, except
phenylalanine-based materials which were referenced to dimethyl sulfoxide (DMSO-d6, δ
2.50 ppm). The hexachlorocyclotriphosphazene trimer and poly[(dichloro)phosphazene]
TROP product were insoluble in CDCl3 and were therefore run in non-deuterated
anhydrous THF with referencing to an external phosphoric acid standard (85% H3PO4, δ
0.0 ppm).
3.6.2

Fourier-Transform Infrared Spectroscopy (FTIR)

Infrared spectroscopy was performed on a Bruker Vector 22 Spectrometer from Bruker
Optics (Bruker Corporation, Billerica, MA) equipped with a MIRacle Attenuated Total
Reflectance (ATR) diamond crystal plate sample cell (PIKE Technologies, Madison,
WI). The samples were run as solid films in air for 32 scans with a resolution of 4 cm-1
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over the scan range of 600 cm-1 to 3200 cm-1. Spectra were collected and processed in
Opus 6.5 FTIR software (Bruker Optics) and reported in wavenumbers (cm-1).
3.6.3

Thermogravimetric Analysis (TGA)

Thermal decomposition of the polymers was determined using TGA on a SDT Q600 TA
Instrument (TA Instruments – Waters LLC, New Castle, DE). A sample of 5 – 15 mg was
placed in an aluminum cup and heated at a rate of 20°C/min from room temperature to
500°C under dry nitrogen atmosphere.
3.6.4

Differential Scanning Calorimetry (DSC)

Glass transition temperatures (Tgs) and melting temperatures (Tms), if applicable, were
determined using a DSC Q20 TA Instrument. A sample of approximately 5 –15 mg was
placed in an aluminum pan and subjected to a heat/cool/heat temperature profile ranging
from -100 to 100°C. The experiments were performed under dry nitrogen atmosphere at a
heating rate of 10°C/min and all Tgs were collected from the second heating cycle.
3.6.5

Gel Permeation Chromatography (GPC)

Molecular weights and polydispersities were obtained from Gel Permeation
Chromatography (GPC) experiments generously performed by PolyAnalytik Inc.
(London, ON). The experiments were conducted on a Viscotek TDA 302 GPC/SEC
Instrument (Malvern Instruments, Malvern, UK) equipped with a triple detection system
(Refractive Index (RI), Right Angle and Low Angle Light Scattering (RALS/LALS), and
Four Capillary Differential Viscometer).

There were four styrene-divinylbenzene

SupeRes™ size exclusion columns (PolyAnalytik Inc., London, ON) connected in series,
PAS-105, PAS-104, PAS-103, and PAS-102.5, with exclusion limits of 4 × 106, 4 × 105,
7 × 104, and 2 × 104 Daltons (Da), respectively. Samples (10mg/mL) dissolved in the
eluent, consisting of 10 mM tetra-n-butylammonium nitrate in THF at 30°C, were passed
through a 0.22 μm Teflon filter prior to injection (100 μL) into the instrument at a flow
rate of 0.7 mL/min. The absolute molecular weights (number average (Mn) and weight
average (Mw)) and polydispersities (PDI, Mw/Mn) were obtained using the triple detection
method and are presented in Daltons (Da, g/mol).

Molecular weights of the
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polyphosphazenes were also calculated relative to polystyrene standards with known
molecular weights using refractive index detection.

3.7
3.7.1

Cytotoxicity Studies of Polymeric Films Using MTT Assays
Thin Film Preparation

Thin films were prepared by adding 30.5 μL of a 1% weight by volume (w/v) solution of
the polymer in absolute ethanol to the bottom of the well of a 96-well tissue culture plate
(BD Falcon™, Franklin Lakes, NJ). The films were allowed to dry at room temperature
for 24 hours. Uncoated tissue culture polystyrene (TCPS) were used as positive controls
in these experiments. The tissue culture plate, including the dried films, was disinfected
with ultraviolet (UV) light overnight. For pre-conditioning, the films were treated with
Hank’s Balanced Salt Solution (HBSS, 200 μL, Invitrogen Canada Inc., Burlington, ON)
at room temperature overnight.
3.7.2

Fibroblast (NIH-3T3) Cell Study

Cell toxicity and proliferation assays were assessed using mouse embryonic fibroblasts
(NIH-3T3 cell-line), which were seeded in the 96-well plate at a seeding density of 8,000
cells/well with 200 μL/well of advanced DMEM (GIBCO® Invitrogen, Burlington, ON,
Canada) containing 5% FBS, 1% antibiotics, and 0.2 mM L-glutamine. The cells were
maintained in a humidified incubator at 37°C and 5% CO2. At time points of 1, 3, and 5
days cells were analyzed for viability using the MTT assay protocol described below.
3.7.3

MTT Assay Protocol

Cell toxicity and proliferation were quantified by colorimetric assays of the metabolic
activity of viable cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) (Vybrant® MTT Cell Proliferation Assay Kit, Invitrogen Canada Inc.)
The MTT tetrazolium dye is reduced to insoluble formazan salts in correspondence to the
activity level of NADPH-dependent oxidoreductase enzymes of metabolically active cells
producing a purple colour.

The concentration of the formazan salts, and therefore

metabolic activity level of the cells present, is determined using optical density at λ = 570
nm. At time points of 1, 3, and 5 days, the spent culture media was aspirated and replaced
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with fresh media (100 μL) followed by MTT (10 μL, Component A) and allowed to
incubate for 4 hours. Sodium dodecyl sulphate (SDS) in dilute acid (100 μL, Component
B) was added to the wells to solubilize the water insoluble formazan salts upon thorough
mixing and incubation for another 4 hours.

The resultant coloured solution was

quantified using a BioTek EL307C multiplate reader (BioTek Instruments, Inc.,
Winooski, VT) at the maximum absorbance wavelength of the formazan solution (570
nm). The results of the MTT assays presented as the mean ± standard deviation for
experiments conducted with 5 replicates (n=5). Statistical analysis was determined from
two-way ANOVA with Bonferroni post-tests using GraphPad Prism 4 (GraphPad
Software, Inc., La Jolla, CA), where a p<0.05 was deemed statistically significant.

3.8
3.8.1

Cell Morphology and Adhesion Studies on Polymer Films Using
Confocal Microscopy
Thin Film Preparation

Polymer film-coated coverslips were prepared by twice dip-coating glass coverslips (12
mm diameter) in 1% w/v solutions of the polymers in absolute EtOH. After each coat the
films were allowed to dry overnight at room temperature in vacuo. Once both coats had
been thoroughly dried in vacuo, one glass coverslip was placed in each well of a 24-well
tissue culture plate. Uncoated glass coverslips were used as a positive control in these
experiments. The cells were seeded at a density of 30,000 cells/well and cultured for 3
days prior to fixation and staining.
3.8.2

Cell Fixation, Staining, and Imaging

For immunostaining studies, cells were washed with PBS pre-warmed to 37°C
immediately prior to fixing at ambient temperature for 10 min in 4% paraformaldehyde
solution (1 mL; EMD Chemicals, Gibbstown, NJ) in divalent cation-free PBS. Following
3 washes in PBS, permeabilized with 0.1% Triton X-100 (0.5 mL; VWR International,
Mississauga, ON) in PBS for 5 min and again washed 3 times with PBS. Following 3
washes in PBS, the cells were incubated in the dark at ambient temperature with Alexa
Fluor® 568-conjugated phalloidin (1:50 dilution; Invitrogen Canada Inc., Burlington,
ON) for 20 min in a 1% BSA/PBS solution to label the F-actin of the cytoskeleton
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followed by another 3 washes with PBS. The fibroblasts were then counterstained with
4’-6-diamidino-2-phenylindole dihydrochloride (DAPI, 300 nM in PBS, 0.5 mL;
Invitrogen Canada Inc., Burlington, ON) for 5 min to label the nuclei and again washed 3
times with PBS. Coverslips were mounted on microscope slides with SHURMountTM –
Toluene Based Liquid Mounting Media (Triangle Biomedical Sciences, Inc., Durham,
NC). Samples were analyzed with a Zeiss LSM 5 Duo confocal microscope with 9 laser
lines and appropriate filters (Carl Zeiss Canada Ltd., Toronto, ON).

3.9

Electrospinning of Polyphosphazenes and Polyphosphazene/
Polycaprolactone Blends

3.9.1

Electrospinning Parameters

Two approaches were investigated to develop 3-D fibers of the polyphosphazene
materials. Solutions of poly[bis(ethyl alanato)phosphazene] (PNEA) alone and a mixture
of PNEA and polycaprolactone (PCL, Mn = 80kDa, Sigma-Aldrich, Oakville, ON,
Canada) in various solvents and co-solvent mixtures using chloroform (CHCl3), N,Ndimethylformamide

(DMF),

ethanol

(EtOH),

tetrahydrofuran

(THF),

and

dichloromethane (DCM) were attempted to be electrospun. The polymer solutions ranged
in concentration from 3 to 37 % w/v and all solvents were from Caledon Labs except
ethanol, which was from Commercial Alcohols Inc. The viscous polymer solutions were
loaded into 0.5 mL glass syringes (Becton, Dickinson and Co., 0.5 cc, New Jersey, USA)
equipped with blunt-tip stainless steel needles between 18- and 22-gauge (inner diameter
0.838 – 0.413 mm). An alligator clip was attached to the middle of the needle connecting
it to the high voltage DC power supply (ES30P, Gamma High Voltage, USA) with an
applied voltage between 7 and 20 kV and a syringe pump (KD101, KD Scientific, USA)
was used to push the solution through the horizontal syringe and needle at a constant flow
rate of 0.1 mL/h. An aluminium foil-covered static collector placed at a distance of 7 to 9
cm from the needle tip was used to catch the polymer fibers during the electrospinning
process.
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3.9.2

Scanning Electron Microscopy (SEM) Imaging of Electrospun Fibers

The electrospun fibers were visualized using scanning electron microscopy (S- 3400N,
Hitachi, Ltd., Tokyo, Japan). The mat was mounted on carbon-taped aluminum stubs and
coated with 5 nm of osmium using a sputter coating technique (Filgen OPC80T Osmium
Plasma Coater, Filgen Nanosciences & Biosciences Inc., Japan). Secondary electron
detection was achieved at a working distance of 10 mm and accelerating voltages
between 3 and 5 kV at various magnifications. Images were acquired and processed using
ImageJ software (NIH, Bethesda, MD).
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Chapter 4
4
4.1

Results and Discussion
Optimization of Thermal Ring Opening Polymerization

Considering the limitations of the traditional thermal ring opening polymerization
discussed in Chapter 1 and that it requires large amounts of starting material, a facile
polymerization technique was developed in this work. The new method overcame the
restrictions of large-scale synthesis making the procedure more ideal for the development
of novel polyphosphazene biomaterials. The new method also bypassed the requirement
of trimer purification prior to polymerization and handling of all materials in inert
atmosphere using expensive glovebox techniques. The success of the new synthesis
process was achieved by monitoring the reaction progress of 1g polymerizations using
31

P NMR and comparing the relative peak heights and integrations of the starting material

and product. The polymerizations were performed at 230°C for time periods of 20 to 26
hours.

From

the

literature,

it

has

been

well

documented

that

hexachlorocyclotriphosphazene (cyclic trimer) gives rise to a single peak at a chemical
shift of approximately +20 ppm, where as poly[(dichloro)phosphazene] (linear high
polymer) appears as a singlet at approximately -17 ppm.67 As can be seen from Figure
4.1 the expected shifts in

31

P NMR spectroscopic analysis of both the trimer starting

material and PDCP linear precursor coincided with those previously presented in the
literature.
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Figure 4.1: 31P NMR of the time-varied facile polymerization of
hexachlorocyclotriphosphazene (1) to purified poly[(dichloro)phosphazene] (5) at
230°C. Spectra (2), (3), and (4) are for 21, 23, and 25 hour polymerizations,
respectively, without purification.
Polymerizations for longer than 25 hours led to cross-linked materials that were insoluble
and could not be reacted further to produce poly[(amino acid ester)phosphazene]s. From
comparison of relative peak heights and integration values in the time-varied
polymerizations shown in Figure 4.1 and Table 4.1, respectively, the best conversion of
hexachlorocyclotriphosphazene to poly[(dichloro)phosphazene] without cross-linking
was achieved at 25 hours reaction time at 230°C. These reaction conditions were used for
all subsequent polymerizations.
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Table
4.1:
Summary
of
the
time-varied
polymerizations
of
hexachlorocyclotriphosphazene (trimer) to poly[(dichloro)phosphazene] (linear
precursor) with their respective yields and extent of conversion.

4.2
There

Comparison of the Three Macromolecular Substitution Methods
Using Non-Functional Amino Acid Esters
are

two

reported

methods

of

amino

acid

substitution

onto

poly[(dichloro)phosphazene] that have been successfully used to make poly[(amino acid
ester)phosphazene]s.77,

78, 83, 84, 95

Both methods involve forming the free base of the

amino acid ester by reacting the hydrochloride salt of the amino acid ester with
triethylamine under refluxing conditions for 3 hours to 24 hours. The first and most
common method, referred to as the RT 2S reaction in the methods section, performs the
actual substitution reaction at room temperature, whereas the other method, referred to as
the LT 2S reaction, performs the substitution at 0°C in an ice bath. In an effort to
overcome the need to liberate the free base and simplify the overall reaction, a method
that involves adding the hydrochloride salt of the amino acid ester, triethylamine and the
poly[(dichloro)phosphazene] linear precursor all together at one time, named the 1P RT
reaction, was investigated. This method was proposed since TEA, the base used to form
the free base from the hydrochloride salt, is non-nucleophilic and should theoretically not
react in a substitution with the poly[(dichloro)phosphazene] linear precursor.

An

adaptation to the low temperature method described in the literature was also compared,
where refluxing the hydrochloride salt of the amino acid ester with TEA was instead
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performed at room temperature rather than at reflux, followed by substitution onto
poly[(dichloro)phosphazene] at 0°C. The one-pot method was proven successful and the
resulting polymers based on non-functional amino acid ethyl esters were characterized
and analyzed in comparison to both of the previously described methods found in the
literature. The amino acid esters used for this comparison included, alanine ethyl ester
(H-Ala-OEt), phenylalanine ethyl ester (H-Phe-OEt), and methionine ethyl ester (H-MetOEt), since these materials have all been previously reported in the literature with
associated characterization and thermal data.64, 83, 84, 94, 95, 97, 105, 114-118 Also, ethyl esters of
amino acids were chosen since ethanol is one of the anticipated degradation products and
can be easily processed by cells. The amino acids were chosen on the basis of having
side chains that are a short alkyl chain (alanine), a rigid and bulky aromatic chain
(phenylalanine), a long and flexible chain (methionine) and a side chain that contains a
heteroatom (methionine). Incorporating amino acids with very different side chains gives
tunability to the polymers and allows for adjustment of both the degradation and
mechanical properties of the materials to suit the intended biomedical application.83
4.2.1

FTIR, 1H NMR, and 31P NMR Characterization

Structural characterization techniques used to compare the three methods were nuclear
magnetic resonance (NMR) spectroscopy and Fourier Transform Infrared (FTIR)
spectroscopy, which are summarized in Table 4.2.
Table 4.2: Summary table of the yields, 1H NMR, 31P NMR, and FTIR analyses of
PP-A100, PP-F100, and PP-M100 synthesized by the three methods (LT 2S = low
temperature two-step reaction, 1P RT = one-pot room temperature reaction, and
RT 2S = room temperature two-step reaction). Note: As described in the methods
section, the mass of poly[(dichloro)phosphazene] (PDCP) is approximate since it
cannot be dried fully and therefore the percentage yields shown are underestimated
since yield calculations are based on PDCP as the limiting reagent.
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The FTIR spectroscopic analyses for the alanine, phenylalanine, and methionine ethyl
ester polyphosphazenes synthesized using the three different methods are shown in
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Figures 4.2 – 4.4. Enlarged spectra of specific regions to show peak broadening have
been included in the Appendix (Appendix 2 - 4).

Figure 4.2: FTIR comparison of PP-A100’s prepared from three different synthetic
methods. The spectra correspond to L-alanine ethyl ester hydrochloride salt (black),
and PP-A100’s from LT 2S method (blue), 1P RT method (green), and RT 2S method
(red).

Figure 4.3: FTIR comparison of PP-F100’s prepared from three different synthetic
methods. The spectra correspond to L-phenylalanine ethyl ester hydrochloride salt
(black), and PP-F100’s from LT 2S method (blue), 1P RT method (green), and RT 2S
method (red).
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Figure 4.4: FTIR comparison of PP-M100’s s prepared from three different synthetic
methods. The spectra correspond to L-methionine ethyl ester hydrochloride salt
(black), and PP-M100’s from LT 2S method (blue), 1P RT method (green), and RT
2S method (red).
The 1H NMR spectroscopic analyses for the alanine, phenylalanine, and methionine ethyl
ester polyphosphazenes synthesized using the three different methods are shown in
Figures 4.5 – 4.7.
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Figure 4.5: 1H NMR comparison of PP-A100’s prepared from three different
synthetic methods. The spectra correspond to L-alanine ethyl ester hydrochloride
salt (black), and PP-A100’s from LT 2S method (blue), 1P RT method (green), and
RT 2S method (red). All small, unlabeled peaks are impurities that cannot be
removed from dissolution/reprecipitation techniques.
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Figure 4.6: 1H NMR comparison of PP-F100’s prepared from three different
synthetic methods. The spectra correspond to L-phenylalanine ethyl ester
hydrochloride salt (black), and PP-F100’s from LT 2S method (blue), 1P RT method
(green), and RT 2S method (red). All small, unlabeled peaks are impurities that
cannot be removed from dissolution/reprecipitation techniques.
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Figure 4.7: 1H NMR comparison of PP-M100’s prepared from three different
synthetic methods. The spectra correspond to L-methionine ethyl ester
hydrochloride salt (black), and PP-M100’s from LT 2S method (blue), 1P RT method
(green), and RT 2S method (red). All small, unlabeled peaks are impurities that
cannot be removed from dissolution/reprecipitation techniques.
Since the

31

P NMR spectra consist of a broad single or bimodal peak for all of the

poly[(amino acid ester)phosphazene]s, they have been included as tabulated data (Table
4.2) rather than spectra for simplicity. As an example of the changes in 31P NMR from
hexachlorocyclotriphosphazene (trimer) to poly[(dichloro)phosphazene] (PDCP, linear
precursor) to an amino acid ester substituted polyphosphazene, the transition from trimer
to PP-M90E*10 has been included (Figure 4.8).
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Figure 4.8: 31P NMR of the transition from hexachlorocyclotriphosphazene (cyclic
trimer) to poly[(dichloro)phosphazene] (PDCP) and finally to the methionine ethyl
ester and benzyl protected glutamic acid ethyl ester co-substituted polyphosphazene
(PP-M90E*10).
From the FTIR, 1H NMR, and

31

P NMR data it is evident that all of the substitution

methods with all of the non-functional amino acid esters were successful, with the
exception of the low temperature two-step reaction with methionine ethyl ester giving
mixed results.
In the FTIR spectra of the PP-A100’s peaks corresponding to the C-H stretch (alkanes) and
N-H stretch were observed between 3100 - 2700 cm-1, correlating to the side chain
methyl group, α-carbon, and ethyl C-H bonds and the N-H bonds of the amine terminus
of the amino acid, respectively. The sharp peak at 1740 cm-1 corresponds to the C=O
stretch of the ester carbonyl of the amino acid. The P=N of the backbone P-NH bonds
that connect the amino acid esters to the phosphorus atoms in the backbone are observed
as a broadening of peaks between 1210 – 1145 cm-1 in comparison to the already present
peaks from L-alanine ethyl ester itself. A similar phenomenon is observed with the
P-NH, where peaks between 850 – 775 cm-1 are broadened relative to alanine ethyl ester
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alone. The incidence of these peak broadenings, which could realistically be two separate
bands appearing as one, fall within the areas previously attributed to P=N and P-NH
bonds in the literature.64,

103, 105, 114, 119-124

Peak-broadened spectra are included in the

Appendix (Appendix 2) for reference, although these broadened peaks alone are not
sufficient to definitively conclude that the PP-A100 has been formed. As such, 1H and 31P
NMR spectra were collected and analyzed to verify the success of the PP-A100 syntheses.
From the 1H NMR spectra, it is apparent that the appropriate chemical shifts and splitting
that correspond to the types of protons on L-alanine ethyl ester are present, with minimal
impurities. The 1H NMR spectra of the PP-A100 synthesized via the 1P RT method will
be discussed in detail although the PP-A100’s from the other two methods gave similar
spectra with only minor differences in chemical shifts (see Table 4.2). The broad singlet
at a chemical shift of 8.69 ppm with non-integer integration between 1 – 2 protons
represents the protons bound to the amine terminus of the amino acid since it is
somewhat similar to an amide (HRN-P=N vs. HRN-C=O). The amine peak has either not
been observed or is omitted from the literature; thus it was of interest to see this peak in
this work83, 84, 94, 97 Since amine protons do not always appear in 1H NMR spectra based
on whether or not the NMR solvent can undergo hydrogen-deuterium exchange reactions,
the polymer was also analyzed in deuterated methanol (MeOH-d4), a solvent that readily
undergoes exchange, to confirm that this peak corresponded to an amine and not some
other impurity. Upon running 1H NMR of the PP-A100 in MeOH-d4 the peak at 8.69 ppm
disappeared, further confirming the identity of the peak as that of the amine protons. The
non-integer integration for this peak leads us to believe that not all of the nitrogen atoms
have been deprotonated (i.e. 2 protons to 1 proton) after the substitution reaction, leaving
the polymer cationic at some or all of the nitrogen atoms, unlike what has been shown in
the chemical structures reported in the literature that show the nitrogen atoms bearing
only 1 proton and a neutral charge. Next, the multiplet at 4.25 ppm (integration for 3H)
corresponds to the proton on the α-carbon and the two protons of the CH2 of the ethyl
ester. This is slightly different than some literature sources83, 84, 94, 97, 116, which identify
two separate peaks at 4.4 and 4.1 ppm corresponding to the proton on the α-carbon and
ethyl group, respectively, rather than the multiplet for both that is found in this work.
Lastly, the doublet at 1.72 ppm (integration for 3H) and triplet at 1.30 ppm (integration
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for 3H) agree well with the literature with only minor differences in chemical shift. They
correspond to the methyl side chain of the amino acid, which is split into a doublet by the
proton on the α-carbon, and the CH3 group of the ethyl ester, which is split into a triplet
by the two methylene protons of the ethyl group, respectively.
In

31

P NMR analysis of the PP-A100’s, broad humps with chemical shifts between 1.13

and -1.42 ppm were observed, which is comparable to the literature as shifts between 1.10 and -3.50 ppm have been reported and broadened peaks are to be expected with
polyphosphazenes.67 Overall, despite these subtle differences, the PP-A100’s were
successfully synthesized via all three reaction methods.
In the FTIR spectra of the PP-F100’s peaks corresponding to the C-H stretch (alkanes)
and N-H stretch were observed between 3100 – 2700 cm-1. The sharp peak at 1740 cm-1
corresponds to the C=O stretch of the ester carbonyl of the amino acid. The P=N of the
backbone and the P-NH bonds broadening of peaks between 1210 – 1145 cm-1 and 865 –
855 cm-1, respectively, in comparison to the already present peaks from L-phenylalanine
ethyl ester alone. Another peak, which was not observed with the PP-A100’s, but is
observed in the PP-F100’s is the aromatic C-H out of plane vibration from the benzene
ring in the amino acid side chain. Peak broadening spectra are included in the Appendix
(Appendix 3) for reference, although, like with the PP-A100’s, these broadened peaks
alone are not conclusive enough. Therefore, 1H and 31P NMR spectra were also analyzed
to confirm the success of the PP-F100 syntheses.
In the 1H NMR spectra of the PP-F100’s the chemical shifts that correspond to the types of
protons on L-phenylalanine ethyl ester are present, along with a few trace impurities. The
1

H NMR spectra of the PP-F100 synthesized via the 1P RT method will be discussed in

detail although the PP-F100’s from the other two methods gave similar spectra with only
slight differences in chemical shifts (see Table 4.2). The broad singlet at a chemical shift
of 8.71 ppm with non-integer integration between 1 – 2 protons represents the protons
bound to the amino terminus of the amino acid. Like with the PP-A100’s, this integration
indicates that some or all of the nitrogen atoms are likely to have 2 protons, implying a
positive charge. The multiplet at 7.30 ppm (integration for 5H) corresponds to the
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aromatic protons of the benzene ring in the phenylalanine side chain, which is not far off
of the 7.6 ppm peak reported in the literature84, 95 and still falls in the typical range for
aromatic protons (8.5 – 6.0 ppm). The proton attached to the α-carbon of the amino acid
was observed as a multiplet with a chemical shift of 4.24 ppm. The quartet of doublets at
4.09 ppm (integration for 2H) signifies the methylene of the ethyl group since the two
protons are each split by the terminal CH3 of the ethyl group, yet they each have their
own unique magnetic environments and appear at slightly different chemical shifts giving
rise to the overlap of two quartets slightly offset from one another. Two doublets of
doublets at 3.21 ppm (integration for 1H) and 3.06 ppm (integration for 1H), represent
the two protons on the methylene group of the phenylalanine side chain. Both of these
protons see the α-carbon splitting them into a doublet and, like the protons described
above, they also have their own unique environments and thus split each other leading to
the doublet of doublet that is observed. Lastly, the triplet at 1.08 ppm (integration for 3H)
corresponds to the CH3 of the ethyl group, which is split by the two methylene protons on
the adjacent carbon.
In

31

P NMR analysis of the PP-F100’s, broad singlets or bimodal humps with chemical

shifts between -0.97 and -9.12 ppm were observed although no data has been reported in
the literature for mono-substituted PP-F100 polymers. There was only one spectrum that
gave rise to a bimodal hump, that being the PP-F100 made via the room temperature twostep method, which may suggest that incomplete substitution occurred. This is postulated
since the chemical shift of PDCP where chlorine atoms are the only substitute gives rise
to a chemical shift of -17.27 ppm and -9.12 ppm, which is somewhat in between the
single peak PP-F100 chemical shifts observed at -1.55 and -0.97 ppm and that of PDCP.
Therefore, it is proposed that the hump at -9.12 ppm corresponds to phosphorus atoms
with 1 L-phenylalanine ethyl ester and 1 chlorine substituent, which could be due to the
increased steric hindrance of the bulky phenylalanine groups in comparison to both
alanine and chlorine substituents. Overall, despite these minor differences the PP-F100’s
were successfully synthesized via all three reaction methods according to FTIR, 1H NMR
and

31

P NMR characterization, although substitution may be incomplete in the room

temperature two-step reaction.
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Peaks from the C-H stretch (alkanes), N-H stretch, and C=O stretch of the ester carbonyl
gave rise to peaks at wavenumbers similar to those of PP-A100’s and PP-F100’s. Also, the
P=N of the backbone and the P-NH bonds showed broadening of peaks between 1210 –
1145 cm-1 and 855 – 840 cm-1, respectively, in comparison to the already present peaks
from L-methionine ethyl ester alone. Peak broadening spectra are included in the
Appendix (Appendix 4) for reference. 1H and

31

P NMR spectra were also analyzed to

prove the success of the PP-M100 syntheses.
The chemical shifts in the 1H NMR spectra of the PP-M100’s relate to the types of protons
present in L-methionine ethyl ester. The 1H NMR spectra of the PP-M100 synthesized via
the 1P RT method will be discussed in detail although the PP-M100’s from the other two
methods gave similar spectra with only slight differences in chemical shifts (see Table
4.2). The broad singlet peak at a chemical shift of 8.84 ppm represents the protons on the
amino terminus of the amino acid ester and integrates for a non-integer value between 1 –
2 protons indicating full or partial cationic charge at the nitrogen atom. In the PP-M100
synthesized via the low temperature two-step method this peak is not present, which
could indicate that the nitrogen atoms were fully deprotonated after substitution and are
more capable than their protonated cationic counterpart at interacting in a hydrogendeuterium exchange reaction with the solvent. It could also indicate that the amine
protons are some how lost and that the reaction did not proceed as expected, although the
first scenario is probably more likely since 1H NMR spectra of poly[(amino acid
ester)phosphazene]s lacking the amine protons are common in the literature.95,

118

The

multiplet at 4.28 ppm (integration for 3H) corresponds to the proton on the α-carbon and
the methylene protons of the ethyl group. The methylene protons of the methionine side
chain appear at 2.79 and 2.38 ppm as multiplets with integration for 2 protons each. The
singlet at 2.13 ppm (integration for 3H) represents the methyl group next to the sulfur
atom in the methionine side chain, which is isolated from other protons by distance and
therefore is unsplit. Finally, the triplet at 1.32 ppm (integration for 3H) symbolizes the
methyl of the ethyl group, which is split into a triplet by the two protons of the adjacent
methylene group.
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In

31

P NMR analysis of the PP-M100’s, broad humps with chemical shifts between 3.51

and -0.43 ppm were observed which is comparable to the literature as a shift of -0.226
ppm has been reported.118 Taken together, PP-M100’s were successfully synthesized via
all three reaction methods except for slight differences in characterization spectra with
the LT 2S method, although low yields and more demanding procedures have prevented
further exploration of materials synthesized via the LT 2S method.
Upon analysis of the PP-A100, PP-F100, and PP-M100 polymers synthesized via the three
substitution methods using FTIR, 1H NMR, and

31

P NMR spectroscopy, it was

determined that there was very little difference between the LT 2S and 1P RT methods, in
terms of successful substitution and purity, and further characterization and comparison
would only be performed on polymers made from the well-established RT 2S and the
new 1P RT methods. This decision was also influenced by the improved yields of the
one-pot synthesis over the LT 2S procedure (see Table 4.2).
4.2.2

TGA, DSC, and GPC Characterization

TGA and DSC were used to analyze the thermal properties of the materials, including
their decomposition temperature (Td), glass transition temperature (Tg), and melting
temperature (Tm), if applicable. Tabulated data from both TGA and DSC analyses has
been included in Table 4.3. The TGA analyses of the 1P RT and RT 2S synthesized
materials are included in Figure 4.9.
Table 4.3: Summary of thermal data from TGA and DSC analysis for PP-A100, PPF100, and PP-M100 materials synthesized via either the 1P RT or RT 2S method. The
decomposition temperatures are presented as the peak decomposition temperatures
rather than onset, meaning they are the values of maximal rate of change in weight
% for all phases of the decomposition (i.e. maxima of the derivative of weight %
plot).
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Figure 4.9: TGA analysis for the PP-A100, PP-F100, and PP-M100 materials prepared
using the 1P RT and RT 2S methods. The top graph represents the weight percent
vs. temperature, where as the bottom graph shows the derivative of weight percent
vs. temperature.
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From the TGA analyses, it is clear that the phenylalanine-based polyphosphazenes (PPF100’s) were the most thermally stable materials as can be seen by their higher
temperature of decomposition onset in comparison to the PP-A100 and PP-M100 materials.
This is due to the increased rigidity of the bulky aromatic side chain with very stable C=C
bonds. The PP-A100 and PP-M100 materials on the other hand do not contain any C=C
bonds in their side chains and thus decomposed at lower temperatures. The bimodal
decomposition profile of the PP-F100’s (which is more obvious from the derivative of
weight % plot) can be accounted by the initial decomposition of the amino acid backbone
in the first peak and followed by the actual decomposition of the aromatic ring of the side
chain in the second peak. For the PP-M100’s, which had the second highest onset
decomposition temperature, there was also a two-phase decomposition that occurred,
with the first peak likely corresponding to the decomposition of the amino acid backbone,
like in the PP-F100’s, followed by decomposition of the methionine side chains. It is
likely that the PP-M100’s had the intermediate decomposition temperature due to their
long aliphatic chains in comparison to the short methyl and bulky aromatic side chains of
alanine and phenylalanine, respectively. Lastly, the PP-A100 materials had the lowest
decomposition onset temperature due to their small aliphatic side chain containing only
C-C and C-H bonds. The decomposition of these materials were primarily single stage
with a slight hump on the edge of the curves indicating that both the backbone and the
side chain of the amino acids degraded at approximately the same temperature. Overall,
decomposition onset temperatures for all of the materials were in excess of 140°C
although the individual peak Td values have been included in Table 4.3. The
decomposition temperatures of poly[(amino acid ester)phosphazene]s are not well
recorded in the literature besides one paper that cites the Tds of PNEA and PNEF as 136
and 185°C, respectively.84 The reason that the decomposition profiles do not completely
reach a weight % of zero is that the inorganic backbone components (P=N and P-N
bonds) decomposes at temperatures in excess of 500°C and these temperatures are not
reached in these experiments.
The DSC thermograms of the one-pot room temperature and room temperature two-step
synthesized materials are included in Figure 4.10.
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Figure 4.10: DSC thermograms of PP-A100, PP-F100, and PP-M100 materials
prepared using the 1P RT and RT 2S methods. The glass transition temperatures
(Tgs), which were collected from the second heating cycle, range from -41.8 to
+46.3°C.
From the DSC, it is evident that the polymers based on the three different amino acids
give rise to materials with substantially different Tg values, which is important with
respect to scaffold fabrication. Ideal scaffold materials should have Tgs near body
temperature (37°C) so that they exhibit properties of both the rubbery and glassy
material, which better mimics the natural ECM. The rubbery characteristics are ideal for
cell-material interactions that enhance cell proliferation on the materials, whereas the
hard and brittle characteristics impart mechanical strength to the scaffold as it acts as a
support material for neo-tissue growth.125-128 The bulky and rigid aromatic ring in the
side chain of phenylalanine increases the Tgs of PP-F100’s (42.8 to 46.3°C) in comparison
to both PP-A100’s and PP-M100’s, which is in agreement with the literature where alanine,
phenylalanine, and methionine based polyphosphazenes have Tgs in the order of PNEA ≈
PNEM < PNEF.83, 84, 94, 95, 97, 115, 116, 118 The steric hindrance of the bulky aromatic side
chains of phenylalanine decreases movement in the polymer backbone thus increasing
their Tgs. This trend is maintained as the PP-M100’s (-23.3 to -19.4°C) have Tgs that are
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similar to the PP-A100’s and lower than PP-F100’s. The increased flexibility of the
aliphatic side chain in methionine in comparison to the rigid ring structure in
phenylalanine lowers the Tgs of the PP-M100 materials. The substantial difference in Tg
values for the PP-A100’s prepared using the two different methods may be due to large
differences in molecular weights, which is known to have an effect on glass transitions in
low molecular weight materials.129 Another possibility is that residual solvent could have
had a plasticizing effect on the RT 2S synthesized material, thus giving the appearance of
a decreased Tg value. Overall, the Tgs for the PP-A100’s synthesized in this work fall
outside of the range of Tgs presented in the literature (-10 to 19°C),83, 84, 94, 97, 116 but again
this could potentially be accounted for by significant differences in the molecular weights
of the materials, as they are prepared using different methods. When comparing the
literature cited PNEFs (40 to 68°C)84, 95 to the Tgs of the PP-F100’s prepared in this work
they are very similar with Tgs ranging from 42.8 to 46.3°C, which is promising. To the
best of our knowledge only one Tg for PNEM has been reported in the literature (9°C),118
so comparison of this work to that single study should be taken with caution, although the
Tgs of the PP-M100’s synthesized in this work are far lower than the cited Tg, they are on
par with the PP-A100’s, which is in agreement with the literature.
The molecular weights of the polymers synthesized were determined by means of GPC
using triple-detection (light scattering, refractive index, and viscometry). Light scattering
detection relies on monitoring the changes in refractive index of the polymer solutions
with varying concentrations, also known as the differential index of refraction or the
refractive index increment (dn/dc), to determine absolute molecular weights.130 This
method gives the most accurate results if changes in dn/dc values are large enough, which
is not always the case. In the event that dn/dc values are too low, other detection
methods such as refractive index can be employed and molecular weights can be
determined by comparing the materials to standards such as polystyrene. For this work,
light scattering determination of absolute molecular weights was attempted for all
materials, although in some cases dn/dc were too low and relative molecular weights
(relative to polystyrene) were determined instead. Table 4.4 summarizes the GPC data
for the polyphosphazenes based on non-functional amino acids.

75

Table 4.4: GPC analysis of PP-A100, PP-F100, and PP-M100 materials using triple
detection and refractive index detection. A (-) indicates that analysis using that
detection method was not possible and the relative molecular weights are calculated
based on polystyrene standards.

As an example of the overlap of the traces collected from GPC for the triple detection
method, the traces from all four detectors (refractive index, right angle light scattering,
low angle light scattering, and viscometery) for the PP-M100 material synthesized via the
one-pot room temperature method has been included in Figure 4.11. Only the refractive
index traces are included for the remaining polymers, which can be seen in Figure 4.12.
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Figure 4.11: Detector signal versus retention volume (mL) traces from GPC analysis
of PP-M100 synthesized via the 1P RT method. Detector traces correspond to
refractive index (red), right angle light scattering (green), low angle light scattering
(black) and viscometer (blue).

Figure 4.12: GPC traces from the refractive index detector for PP-A100 (----1P RT, - - RT 2S), PP-F100 (---- 1P RT, - - - RT 2S), and PP-M100 (---- 1P RT, - - - RT 2S).
The traces from the four detectors (Figure 4.11) overlap well indicating that readings
from all of the detectors corroborate with each other. As such, the light scattering
detection traces and measured dn/dc values can be used to determine the absolute
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molecular weights of the polymers with the assumption that the materials are
homopolymers and therefore, there are no unsubstituted P-Cl bonds remaining in the
materials.130 This is a reasonable assumption for all of the materials except the PP-F100
synthesized via the room temperature two-step method as it gave 2 signals rather than 1
in

31

P NMR, indicating the possibility of a partially substituted polymer (likely some

phosphorus atoms with only one phenylalanine ethyl ester attached and a remaining P-Cl
bond rather than two phenylalanine ethyl esters attached). Therefore, the absolute
molecular weights for PP-F100 1P RT, PP-M100M 1P RT, and PP-M100 RT 2S can be
considered valid. Another note to consider with light scattering detection for absolute
molecular weight analysis is that PDI values are underestimated using this technique and
should be taken with caution.130 Unfortunately, similar polyphosphazenes have not been
analyzed using a triple detection method for GPC in published literature and therefore the
values determined in this work cannot be compared to cited values.
For the polymers that could not be analyzed via light scattering detection due to low
dn/dc values, refractive index detection was used instead and molecular weights were
calculated relative to polystyrene standards (see Table 4.4). From the refractive index
traces (Figure 4.12), it is evident that PP-F100 materials tend to give rise to bimodal
chromatograph indicating that there is likely a mixture of high and low molecular weight
polymers, which is also evident from the large PDIs. Overall, the relative molecular
weights of the non-functional amino acid ester based polyphosphazene materials of this
work appeared to be lower than those of the literature.83, 84, 94, 97, 115, 117, 118 This is likely
due to the presence of moisture during the polymerization and substitution steps of the
synthesis in the new techniques. Moisture has been shown to initiate premature
hydrolysis of the materials leading to decreased molecular weights.81 It is interesting to
note that the molecular weights of the materials from the one-pot method are higher than
those from the traditional two-step reaction, indicating that this method may even
increase molecular weights further if applied to inert atmosphere reactions. This was
surprising as lower pH solutions have been shown to increase the rate of degradation of
poly[(amino acid ester)phosphazene]s and forming the free base in solution during the
substitution has the potential to release hydrochloric acid.81 The exception to this is with
the PP-F100 materials but the relative molecular weights of the RT 2S are vastly different
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than the remainder of the materials and should be considered with caution. The two
peaks in the 31P NMR spectra are also an indication that this material may not actually be
the expected material proposed and therefore comparison to this material should be used
sparingly or not at all. The substantial difference in absolute molecular weights versus
relative molecular weights could be accounted for by differences in behavior of the
polymers in the GPC eluent (10 mM n-butylammonium nitrate in THF). For example,
the conformation of the polystyrene standards may take on a compact shape in an attempt
to exclude the eluent thus giving rise to a smaller hydrodynamic radius, whereas the
polyphosphazenes may take on an extended conformation in which the eluent is free to
interact with the polymer leading to a larger hydrodynamic radius for a polyphosphazene
than polystyrene of the same molecular weight.131 These differences in conformation can
lead to problems in calculating the molecular weights of the polyphosphazenes based on
polystyrene standards. Despite this, poly[(amino acid ester)phosphazene]s based on
alanine ethyl ester, phenylalanine ethyl ester, and methionine ethyl ester, have been
successfully synthesized and characterized (FTIR, 1H NMR,
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P NMR, TGA, DSC, and

GPC) in a non-inert atmosphere with a simplified substitution method that eliminated the
requirement of liberating the free base of the amino acid ester hydrochloride salt prior to
substitution. These two new methods (polymerization and one-pot substitution) will be
applied further for the development of novel materials with functional handles for
biomolecule conjugation.

4.3

Esterification of Fmoc- and Boc-Glu(OBzl)-OH

Although amino acid esters with no functionality in their side chains, like alanine,
phenylalanine, and methionine, are readily available as their hydrochloride salts, amino
acid esters with added functional groups in their side chains, like glutamic acid, aspartic
acid, and lysine, are not and must therefore be synthesized before incorporation into
poly[(amino acid ester)phosphazene]s. Glutamic acid was selected as the functional
amino acid to be co-substituted with the non-functional amino acids of the base polymers
due to its carboxylic acid group that can be used to attach small molecules and proteins
and potentially enhance cell-material interaction. Glutamic acid was chosen over aspartic
acid, which also contains a carboxylic acid group, because of its extra methylene in the
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side chain that extends the functional group out further from the polymer backbone
decreasing the likelihood of unsuccessful biomolecule conjugation due to steric hindrance
alone. Lysine is another viable option as a functional amino acid co-substituent with its
amine group in the side chain, although it was not considered in this work.
Since glutamic acid could not be purchased as the ethyl ester at the C terminus, variations
with the N terminus and side chain carboxylic acid orthogonally protected were acquired
instead and the C terminus was esterified with ethanol in-house. Fmoc and Boc protected
N termini with a benzyl ester protected side chain were selected based on their
availability, as Fmoc and Boc protected amino acids are common in peptide synthesis132,
133

, relatively inexpensive, and mild deprotection conditions are required (mild base and

acid, respectively).134 The benzyl ester protecting group of the side chain was selected on
the basis of its base stability and deprotection using hydrogenation rather than acid,
which could cause cleavage of the amino acid esters or hydrolysis of the
polyphosphazene backbone.134 It is important that the glutamic acid side chain be
protected since it can also act as a nucleophile in the substitution with
poly[(dichloro)phosphazene], which would lead to a mixture of amino acid esters bound
through both the nitrogen of the N terminus and the oxygen of the carboxylic acid side
chain. This could also be problematic as the two reactive sites could react with each
other forming amide bonds and causing crosslinking of the polymers, which is not ideal.
Esterification of the C terminus was attempted using a carbodiimide coupling chemistry
method that was previously reported135. In this cited paper, esterifications on Boc
protected amino acids were attempted, although it was predicted that it may also work for
Fmoc protected amino acids since only catalytic amounts of base were required. In fact
successful esterification of Boc-Glu(OBzl)-OH with methanol (MeOH), t-butanol (tBuOH), and benzyl alcohol (PhCH2OH) nucleophiles was shown135 although ethanol
(EtOH) had not been investigated. In this work, ethyl esterification of both FmocGlu(OBzl)-OH and Boc-Glu(OBzl)-OH were attempted, although initial experiments
with Fmoc-Glu(OBzl)-OH led to a mixture of products as determined by

13

C and 1H

NMR. It is believed that the base-labile Fmoc group was cleaved during the esterification
giving way to potential self-condensation reactions and a plethora of side products, which
could not be removed using standard liquid-liquid extraction purification.

Further
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experiments with Fmoc-Glu(OBzl)-OH were not attempted and esterification of BocGlu(OBzl)-OH was pursued. Boc- Glu(OBzl)-OH was successful esterified with ethanol
via the DMAP and EDC coupling chemistry 135 as determined by 1H NMR analysis of the
starting material in comparison to the esterification product (Figure 4.13). The
appearance of the quartet at 4.16 ppm and the triplet at 1.24 ppm corresponding to the
methylene and methyl protons of the ethyl ester, as well as the disappearance of the broad
singlet at 10.61 ppm from the COOH indicate complete esterification of the C terminus.
The purification of the product was modified from that of the paper by performing the DI
water washes with 60°C DI water rather room temperature since ureas, which are the
byproduct of carbodiimide coupling chemistry, are known to be more water-soluble at
higher temperatures and remain dissolved in the aqueous layer upon cooling.136 Initial
esterifications gave 1H NMR spectra that indicated incomplete removal of urea byproduct
impurities in the Boc-Glu(OBzl)-OEt product but upon implementation of the higher
temperature washes, these impurities were successfully removed leaving only pure BocGlu(OBzl)-OEt.

Before the esterified glutamic acid could be used in substitution

reactions with poly[(dichloro)phosphazene], its amine terminus needed to be deprotected
so that the amine could act as a nucleophile in the substitution reaction.
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Figure 4.13: 1H NMR spectra of the esterification with ethanol and deprotection
with 25% TFA in DCM of Boc-Glu(OBzl)-OH (black). The ethyl esterified product,
Boc-Glu(OBzl)-OEt, is shown blue and the Boc deprotected product, TFA-/H3N+Glu(OBzl)-OEt, is shown in green. Unlabeled peaks in the Boc-Glu(OBzl)-OEt and
TFA-/H3N+-Glu(OBzl)-OEt spectra are equivalent to the labeled peaks with the
same chemical shift in the Boc-Glu(OBzl)-OH spectrum.

4.4

TFA Deprotection of Boc-Glu(OBzl)-OEt

The Boc protecting group on amines has been shown to be removed by 50%
trifluoroacetic acid (TFA) in dichloromethane (DCM), so this deprotection step was
employed to the Boc-Glu(OBzl)-OEt molecule synthesized in Section 3.3.134 From 1H
NMR analysis, it was observed that this concentration of TFA also lead to partial
deprotection of the benzyl ester of the side chain (appearance of a broad singlet at 11.98
and singlet at 2.19 ppm, presumably indicating COOH and toluene, respectively). In an
effort to deprotect the Boc group and minimize concurrent benzyl deprotection, 25%
TFA in DCM was attempted. This method was successful in deprotecting the Boc group
while maintaining the integrity of the benzyl ester as is shown in Figure 4.13, which is
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observed as a disappearance of the singlet at 1.24 ppm corresponding to the Boc
protecting group and the appearance of a broad singlet at 8.29 ppm which represents the
amine protons.

4.5

Macromolecular Co-Substitution of Functional and NonFunctional Amino Acid Esters

In order to improve cell-material interactions, more often than not biomolecules are
attached to the materials, either through adsorption or by covalent linkage to the scaffold
itself. With adsorption, the biomolecules can quickly diffuse away from the material
once submerged in culture media or body fluid if the non-covalent interactions are weak
leading to decreased efficiency and minimal improvement in cell-material interactions.53
Conjugation of the biomolecules through covalent bonds, on the other hand, prevents this
diffusion problem and maintains the biomolecule at the material surface, ideally leading
to a sustained and enhanced effect on the cell-material interactions.

As such, the

development of materials containing functional handles for biomolecule attachment is
being actively pursued.53 In this work, glutamic acid, with its carboxylic acid functional
group in the side chain, was explored as a co-substituent in poly[(amino acid
ester)phosphazene]s, giving the mixed polymers a reactive site for biomolecule
conjugation.
Initial substitution reactions investigated the sequential addition of the amino acid esters,
where the bulkier substituent (glutamic acid ethyl ester in this case) was reacted first,
followed by the less bulky amino acid ester (alanine ethyl ester, phenylalanine ethyl ester,
or methionine ethyl ester) in excess, as is described in the literature. In these reactions,
the polymer precipitated out of solution before complete substitution was achieved,
making co-substitution via this method unfeasible. This problem is likely due to the
glutamic acid ester substituents being already bound either directing the subsequent
substitution in a tactic fashion that leads to an insoluble polymer or that the glutamic acid
substituents cause crosslinking in the polymer also leading to insolubility issues.
Therefore, a new step-wise synthesis was employed that reacted half of the total less
bulky and non-functional amino acid ester first, followed by all of the required amount of
glutamic acid ester, and completion of substitution with an excess of the non-functional
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amino acid ester. The reasoning behind this method was to eliminate the proposed
glutamic acid interactions described above that lead to precipitation by partially
substituting the poly[(dichloro)phosphazene] with the non-functional amino acid esters,
which prevent the glutamic acid ester substituents from grouping together. This method
was used to make polymers with approximately 90% substitution of the non-functional
amino acid ester and 10% benzyl protected glutamic acid ethyl ester. These functional
polymers (PP-A90E*10, PP-F90E*10, and PP-M90E*10) were then characterized by FTIR, 1H
NMR,
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P NMR, TGA, DSC, and GPC and compared to their non-functional base

polymers made from the one-pot room temperature synthesis method. It was not possible
to compare the characterization data to literature values, as these are novel compounds
that have not been previously published.
4.5.1

FTIR, 1H NMR, and 31P NMR Characterization

Table 4.5 summarizes the spectroscopic characterization using FTIR, 1H NMR, and
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P

NMR along with percent yields for the three poly[(amino acid ester)phosphazene]s cosubstituted with a non-functional amino acid ester (alanine, phenylalanine, or methionine)
and the functional glutamic acid ethyl ester.
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Table 4.5: Summary of percent yields, 1H NMR, 31P NMR and FTIR
characterization of the co-substituted poly[(amino acid ester)phosphazene]s.

The FTIR spectra of the co-substituted poly[(amino acid ester)phosphazene]s in
comparison to their parent base polymers and TFA-/H3N+-Glu(OBzl)-OEt are shown in
Figures 4.14 – 4.16.
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Figure 4.14: FTIR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-A90E*10 (red) ,
and PP-A100 synthesized via the 1P RT method (blue).

Figure 4.15: FTIR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-F90E*10 (red) ,
and PP-F100 synthesized via the 1P RT method (blue).
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Figure 4.16: FTIR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-M90E*10 (red) ,
and PP-M100 synthesized via the 1P RT method (blue).
The overlapped 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt, the co-substituted
poly[(amino acid ester)phosphazene]s, and their base non-functional polyphosphazenes
for all three of the functional polymers are presented in Figures 4.17 – 4.19.
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Figure 4.17: 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-A90E*10,
(red), and PP-A100 from the 1P RT method (blue).

Figure 4.18: 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-F90E*10
(red), and PP-F100 from the 1P RT method (blue).
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Figure 4.19: 1H NMR spectra of TFA-/H3N+-Glu(OBzl)-OEt (black), PP-M90E*10
(red), and PP-M100 from the 1P RT method (blue).
From the FTIR and

1

H NMR of all of the co-substituted poly[(amino acid

ester)phosphazene]s, it is clear that the benzyl protected glutamic acid ethyl ester
substituent has been successfully incorporated as a co-substituent in all of the materials.
This was demonstrated by the presence of FTIR peaks from both the base
polyphosphazene material (PP-A100, PP-F100, and PP-M100) and from the TFA-/H3N+Glu(OBzl)-OEt amino acid ester substituent. For example, in the PP-A90E*10 FTIR
spectrum we see a peak at approximately 1740 cm-1 that corresponds to the C=O of the
ester group of the amino acid backbones and another peak at approximately 1660 cm-1
that identifies the C=O of the ester group in glutamic acid side chain. In 1H NMR spectra
of the co-substituted poly[(amino acid ester)phosphazene]s, the peaks with correct
chemical shift and multiplicity that are equivalent to the parent non-functional polymer
and glutamic acid ethyl ester substituent are all present. For example, in PP-A90E*10 the
multiplet at 7.23 ppm corresponds to the aromatic protons of the benzyl protecting group
in glutamic acid ethyl ester, whereas the triplet at 1.18 ppm represents the terminal CH3
group of the ethyl ester on alanine. From 31P NMR, it is again clear that the polymers
were formed with the appearance of a singlet, for all except PP-F90E*10, around 0 ppm
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and the disappearance of the singlet at approximately -17 ppm for

the

poly[(dichloro)phosphazene] linear precursor (see Table 4.5 for exact chemical shifts).
In the case of PP-F90E*10 a two-hump peak was again observed like with the PP-F100
synthesized via the RT 2S method. In this case, the peak could again correspond to
phosphorus atoms that have residual chlorine atoms bound but could also indicate
tacticity in the polymer where initial phenylalanine substitution directs the incorporation
of the glutamic acid ester co-substituent. Two peaks in the
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P NMR could potentially

indicate that the phenylalanine ethyl ester substituents selectively attached on either side
of the same phosphorus atom, giving rise to one of the peaks, leaving the glutamic acid
ester substituents to also attach to the same phosphorus atom as themselves, giving rise to
the second peak (i.e. phosphorus atoms with two phenylalanine groups and others with
two glutamic acid groups).
Considering that in 1H NMR peak areas correlate to relative numbers of protons,
integration of the peaks solely from the non-functional amino acid ester and solely from
the functional glutamic acid ester were compared to determine the amounts of each of the
co-substituents on the polymer. The reaction schemes were designed to theoretically
incorporate 10% of benzyl protected glutamic acid ethyl ester with the remaining 90%
being substituted by the non-functional amino acid esters although steric hindrance and
other factors may have limited the actual amount of the glutamic acid ester that was
actually incorporated. The experimentally determined percentages of benzyl protected
glutamic acid ethyl ester substituents were 6.8, 7.7, and 9.3% for the PP-A90E*10, PPF90E*10, and PP-M90E*10, respectively.
4.5.2

TGA, DSC, and GPC Characterization

This next section describes the thermal properties and molecular weights of the functional
polyphosphazenes. As with the non-functional base polymers, thermal data was collected
to determine the decomposition, glass transition, and melting temperatures, where
applicable, for all of the functional polymers co-substituted with benzyl protected
glutamic acid ethyl ester and results are summarized in Table 4.6.
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Table 4.6: Summary of thermal data from TGA and DSC analysis for PP-A90E*10,
PP-F90E*10, and PP-M90E*10 polymers. The decomposition temperatures are
presented as the peak decomposition temperatures rather than onset, meaning they
are the values of maximal rate of change in weight % for all phases of the
decomposition (i.e. maxima of the derivative of weight % plot).

Thermogravimetric (TGA) analysis data showing thermal decomposition properties are
shown in Figure 4.20.
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Figure 4.20: TGA analysis for the PP-A90E*10, PP-F90E*10, and PP-M90E*10 polymers.
The first graph represents the weight percent vs. temperature, where as the second
graph shows the derivative of weight percent vs. temperature.
From TGA analyses, all three of the polymers exhibited similar thermal stability with
onset of decomposition in excess of approximately 150°C for all. Unlike the single phase
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decomposition observed with the PP-A100 base polymer, all of the functional
polyphosphazenes showed two-step decomposition processes, similar to PP-F100 and PPM100. The reason behind the two-step decompositions with the functional polymers is the
presence of the C=C bonds aromatic bonds of the benzyl protecting group, and
phenylalanine side chain in PP-F90E*10, which give rise to the second peak of the process
as these bonds are more stable than the C-C and C-H bonds of the amino acid backbone.
All of the TGA traces were relatively similar to one another, which is to be expected
when the all contain not only C-C and C-H bonds but also the more stable C=C bonds.
Like with the non-functional base polymers, the decomposition profiles do not
completely reach a weight % of zero since the inorganic backbone of the
polyphosphazenes does not decompose in the temperature range of the experiments.
The differential scanning calorimetry (DSC) analyses of the functional polyphosphazenes
are presented in Figure 4.21.

Figure 4.21: DSC thermograms of PP-A90E*10, PP-F90E*10, and PP-M90E*10
polymers. The glass transition temperatures (Tgs), which were collected from the
second heating cycle, range from -49.4 to +44.5°C.
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Overall the Tgs of the functional polymers follow the same trend as those of the nonfunctional base polymers, where the Tgs are in the order PP-A100 ≈ PP-M100 < PP-F100.
Due to the small percent substitution of the glutamic acid substituent, approximately
10%, the functional polymers are expected to have Tgs on par with their non-functional
counterparts. The Tgs are also in approximately the same range as for the base polymers
except with the methionine based functional polymer, which is much lower than the base
polymers. This is likely due to the role that molecular weight plays in the glass transition
temperature of polymers.
Like with the non-functional polymers, GPC analysis was performed using triple
detection and refractive index detection alone to determine the absolute and relative
molecular weights, respectively.

In this case, since the polymers are no longer

homopolymers their dn/dc must be approximated using their parent non-functional
polymers, leading to uncertainty in the absolute molecular weights calculated from light
scattering-based triple detection methods. Therefore, it is more appropriate to consider
the relative molecular weights that have been calculated based on polystyrene standards
rather than the absolute molecular weights, although the absolute molecular weights have
been included in this work for completeness. The results of GPC analysis of the
functional polyphosphazenes are summarized in Table 4.7.
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Table 4.7: GPC analysis of PP-A90E*10, PP-F90E*10, and PP-M90E*10 materials using
triple detection and refractive index detection. A (-) indicates that analysis using
that detection method was not possible and the relative molecular weights are
calculated based on polystyrene standards.

Figure 4.22: GPC traces from the refractive index detector for PP-A90E*10 (black),
PP-F90E*10 (blue), and PP-M90E*10 (red).
From the refractive index traces (Figure 4.22) it is evident that PP-F90E*10 material
produced a bimodal spectra indicating that there is likely a mixture of higher and lower
molecular weight polymers. Overall, the relative molecular weights of the co-substituted
amino acid ester based polyphosphazene materials are lower than those of the nonfunctional parent polymers. This could be the case if the higher molecular weight
polymers have a tendency to precipitate out of solution prior to complete substitution,
leading to their filtration and loss during the purification steps. This is postulated due to
the fact that initial experiments where benzyl protected glutamic acid ethyl ester was
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added before the non-functional amino acid ester led to problems with precipitation of the
polymers before complete substitution was achieved, indicating that if large amounts
glutamic acid substituents were present on the polymer that solubility issues could arise.
Despite the lower molecular weights of the polymers, overall characterization by FTIR,
1

H NMR,
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P NMR, TGA, DSC and GPC have proven that co-substituted

polyphosphazenes of alanine ethyl ester, phenylalanine ethyl ester, methionine ethyl
ester, and benzyl protected glutamic acid ethyl ester polymers are feasible for the
development of poly[(amino acid ester)phosphazene]s with functional handles for
biomolecule conjugation.

4.6

Hydrogenation of Glutamic Acid Co-Substituted
Polyphosphazenes for Model Compound Conjugation

After the benzyl protected glutamic acid substituent is successfully incorporated into
polyphosphazenes, it is necessary to remove the benzyl ester protecting group to free the
carboxylic acid functionality, as it is this group that allows covalent attachment of
biomolecules. Benzyl esters are commonly removed by either highly acidic conditions,
which would be detrimental to the polymer backbone and lead to ester hydrolysis in this
case, or by hydrogenation using a palladium catalyst. In this work, a Pd/C catalyst system
was attempted for the hydrogenation of the benzyl protecting groups. The effect of
hydrogenation reactions on P=N bonds is not well-documented in the literature, although
their dissimilarity from C=C bonds lead us to believe that they may withstand
hydrogenation conditions. The PP-A90E*10 material was dissolved in anhydrous ethanol
and mixed with a suspension of Pd/C catalyst under an H2 atmosphere for 3.5 hours. The
reaction successfully removed the benzyl esters as indicated by the disappearance of the
multiplet at 7.23 ppm in 1H NMR corresponding to the aromatic protons of the benzyl
group (see red spectrum of Figure 4.12). Unfortunately, the reaction also reduced the
P=N bonds of the polymer backbone and led to backbone cleavage. This was identified
by the disappearance of the peak at around 1.84 ppm in 31P NMR, which is indicative of
the presence of the polymer backbone.

Another indication that the hydrogenation

reaction attacked the polymer backbone was that the materials were water-soluble after
hydrogenation, which is not the case for the intact materials. To overcome this problem
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it is suggested that allyl protected glutamic acid groups should be used in place of benzyl
protected ones. For allyl protecting groups, which are both acid and base stable, a
Pd(PPh3)4 transition metal catalyst be used for deprotection in place of hydrogenation to
prevent disruption of the P=N bonds. Morozowich et al.90 have shown successful
removal of allyl protecting groups on antioxidant substituted polyphosphazenes without
any detriment to the backbone using this catalyst system.

4.7

Cytotoxicity and Cell Proliferation on Non-Functional and
Functional Two-Dimensional Polyphosphazene Films

Upon successful synthesis of the base and functional polymers using the new one-pot
room temperature synthesis method, it was necessary to evaluate the interaction of the
materials with cells to ensure their cytocompatibility. For this, two-dimensional films of
the polymers were coated onto the bottom of the wells of a 96-well tissue culture plate,
then cytoxicity and cell proliferation were analyzed using MTT assays. A mouse
fibroblast cell line (NIH-3T3) was used to evaluate the effect of the polymers on cell
viability and metabolic activity over a time period of five days. Figure 4.23 shows the
metabolic activity of the cells normalized to TCPS at day 1. As can be observed from the
overall comparison of the two graphs in Figure 4.23, preconditioning the materials
overnight in HBSS leads to an increase in initial cell viability (higher absorbances at day
1 with preconditioning), although it does not change the fact that with and without
preconditioning cells are capable of proliferating on the materials over the entire 5-day
span (metabolic activity persists until day 5 on the materials with and without
preconditioning). It is also clear from the confocal microscopy images of Figure 4.25
that the cells on the unconditioned materials (Panels A, C, E, G, I, K, and M) are still
viable based on their elongated morphology with long filamentous F-actin protrusions
(green). Preconditioning is common practice in cell studies with biomaterials as it acts as
a buffering period in which the materials are washed of small molecules on their surface
that can disrupt proper interaction of the cells with the materials themselves.50, 51, 53, 94, 114
Moreover, the preconditioning period “wets” the surface of the materials allowing them
to interact properly with the aqueous cell suspensions, rather than seeding the cells on the
dry films, which may suppress cell-material interaction and lead to diminished cell
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attachment, and thus reduced viability, on the materials. Therefore, all statistical analysis
of comparisons between materials in terms of cell viability and proliferation were
conducted for the preconditioned films. At Day 1, both of the phenylalanine-based
polyphosphazenes (PP-F100 and PP-F90E*10) showed significantly higher (p<0.001)
metabolic activity of fibroblasts in comparison to the TCPS positive control. At Day 3,
the PP-F90E*10 material continues to exhibit significantly higher (p<0.01) metabolic
activity of the cells in comparison with the TCPS control. By Day 5, it seems that cell
proliferation begins to plateau, which may be due to crowding of the fibroblasts, and the
PP-F90E*10 material performs on par with the TCPS control in terms of metabolic activity.
For the PP-F100 material, the metabolic activity of the fibroblasts in comparison to TCPS
was not significant by Day 3. Taken together, these indicate that the phenylalanine-based
polyphosphazenes synthesized via the new 1P RT method are suitable as biomaterials and
should be explored further. For the remainder of the materials, it should be noted that
despite having initial metabolic activity lower than the TCPS controls, these materials are
also non-cytotoxic. This is shown in Figure 4.24, where it is clear that the metabolic
activity is increasing from Day 1 to Day 5 for all of the functional and non-functional
polymers, despite lower initial activity at Day 1, indicating that the cells are thriving on
these materials. The decreased Day 1 activity levels may be due to decreased affinity of
the cells to attach to the materials initially, although once they have successfully attached
they are capable of surviving. The confocal images of the preconditioned materials in
Figure 4.25 (Panels, B, D, F, H, J, L, and N) also shows that the cells are
morphologically healthy and spreading well on the materials.
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Figure 4.23: Fibroblast metabolic activity as determined by MTT assay grouped by
day to compare metabolic activity levels between materials and TCPS. Cells were
seeded at 8,000 cells/well on 2-D polyphosphazene films (PP-A100, PP-F100, PP-M100,
PP-A90E*10, PP-F90E*10, and PP-M90E*10) that were either unconditioned or
preconditioned in HBSS at room temperature overnight. The cells were cultured for
1, 3, and 5 days with 5 replicates for each. The data are presented as the mean ±
standard deviation and are normalized to TCPS at Day 1. (** = p<0.01, *** =
p<0.001)

Figure 4.24: Fibroblast metabolic activity as determined by MTT assay grouped by
material to show non-cytotoxicity from day 1 to day 5. Cells were seeded at 8,000
cells/well on 2-D polyphosphazene films (PP-A100, PP-F100, PP-M100, PP-A90E*10, PPF90E*10, and PP-M90E*10) that were preconditioned in HBSS at room temperature
overnight. The cells were cultured for 1, 3, and 5 days with 5 replicates for each.
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The data are presented as the mean ± standard deviation and are normalized to
TCPS at Day 1.

Figure 4.25: Confocal microscopy images showing the morphology and spreading of
fibroblasts on the unconditioned and preconditioned polyphosphazene materials
after 3 days of culture. The cells were seeded at a density of 30,000 cells/well on the
polymer coated glass coverslips in a 24-well tissue culture plate. Untreated glass
cover slips were used as a positive control in these experiments. The fibroblasts were
stained for F-actin (green) and nuclei (blue). Scale bar = 20 μm (panel B).
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4.8

Electrospinning of Poly[(amino acid ester)phosphazene]s and
PCL Blend Materials

In order for the new materials to be useful in scaffolds for tissue engineering, they must
be processable into 3-D constructs using one of the scaffold fabrication techniques
alluded to in the introduction. As such, preliminary proof of concept, electrospinning
was attempted using PP-A100 materials synthesized via the 1P RT reaction. Since similar
polyphosphazene materials had been successfully electrospun into fibrous mats in the
literature, the electrospinning parameters from these experiments were used as a starting
point. Some difficulties in attempting to implement these conditions with the new PPA100 materials were that the molecular weights of the polymers were vastly different,
therefore requiring changes to the concentrations to maintain sufficient viscosity of the
polymer solution, and also that the solvents used in the literature were relatively toxic
(ex. hexafluoroisopropanol and trifluoroethanol) in comparison to standard solvents (ex.
chloroform, ethanol, and tetrahydrofuran) and thus, suitable replacements were
required.64,

105, 137, 138

It was also suspected that the charged nature of the polymers

synthesized in this work, in comparison to the uncharged polymers of the literature, may
pose a problem with electrospinning since the technique is based on the exploitation of
electrical charges.
Initial trials investigated PP-A100 concentrations between 3 and 37 weight by volume
percent (w/v %) in solvents and co-solvent systems based on CHCl3, DCM, EtOH, THF,
and DMF.

Sufficient viscosities were achieved to form the polymer jet in

electrospinning, although it was noticed that upon hitting the collector the fibers
remained standing up out from the aluminum foil, rather than laying flat on the surface.
This was presumably due to a build up of charges from the positively charged nitrogen
atoms of the polyphosphazene backbone repelling one another and pushing the newly
deposited fibers of the collector towards the needle tip. It is believed that a rotating
mandrel setup, rather than a stationary collector, may help with this problem by forcing
the extended polymer chains to collapse back on one another as the mandrel rotates,
allowing a fibrous mat to be collected.
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Unfortunately, a rotating mandrel setup was unavailable to test this theory and instead
polymer blends of PP-A100 and polycaprolactone (PCL), a well-known biocompatible and
degradable polymer, were attempted to be electrospun as proof that fabricating fibrous
mats of these polymers was feasible. Various w/v % concentrations and ratios of PP-A100
to PCL were attempted, although a mixture of 50% PP-A100 and 50% PCL gave the best
results and was capable of forming non-woven fibers as determined by scanning electron
microscopy (SEM) imaging. The spinning solution was a 5 w/v % solution of 50% PPA100 and 50% PCL by weight in DCM. The electrospinning parameters were an 18kV
accelerating voltage, 18-gauge needle tip, 9 cm working distance between the tip of the
needle and the collector, and flow rate of 0.1 mL/h. Although the electrospinning
parameters were not optimized to give ideal fiber diameters and morphologies, it can be
seen from the SEM images (Figure 4.26) that the polymer blend gave relatively uniform
fiber diameters with a bead-free morphology and good porosity, which are key aspects to
a successful scaffold. Optimization of the electrospinning parameters could enable the
fabrication of fibrous mats based on polyphosphazene/PCL blend materials with
appropriate fiber diameters, morphology, and porosity for vascular tissue engineering
applications.

Figure 4.26: Scanning electron micrographs of electrospun fibers of a 5 w/v %
polymer solution in DCM containing 50% PP-A100/50% PCL by weight.
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4.9

Novelty of This Work

Overall, the research conducted in this thesis has led to the successful synthesis of
polyphosphazene materials based on both non-functional and functional amino acid esters
using a simplified method. The facile synthesis is an improvement over the demanding
techniques previously presented in the literature, overcoming the necessity of specialized
equipment to maintain an inert atmosphere and the use of toxic solvents. The materials
were characterized extensively and exhibited partial cationic charge at the nitrogen atom
of the amino acid, which had not been reported in the literature before with similar
materials. Lastly, novel polyphosphazenes containing mixed substituents of nonfunctional amino acids and functional glutamic acid were synthesized which are materials
that had not been reported prior to this work.
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5
5.1

Conclusions and Future Directions

Conclusions

In this work, the objectives outlined in Chapter 1 were all successfully realized, except
for the biomolecule conjugation due to problems with deprotection. A thermal ring
opening polymerization method that did not require controlled moisture-free atmospheres
was developed and optimized for best conversion of the hexachlorocyclotriphosphazene
trimer to linear poly[(dichloro)phosphazene] (PDCP). From there, the PDCP was
successfully used in the synthesis of a family of non-functional poly[(amino acid
ester)phosphazene]s, based on L-alanine ethyl ester, L-phenylalanine ethyl ester, and Lmethionine ethyl ester, using three different substitution methods. Upon characterization
by FTIR, 1H NMR, and 31P NMR spectroscopic studies, it was determined that all three
methods produced materials which were similar to those described in the literature,
indicating that the new facile one-pot room temperature (1P RT) method, which also
eliminated the necessity of an inert atmosphere, was suitable for future polyphosphazenes
syntheses. The new 1P RT method was selected over the low temperature two-step
method (LT 2S), based on yields and characterization data, for further comparison to the
materials synthesized via the room temperature two-step (RT 2S) method in terms of
thermal and molecular weight analysis. It was also observed that the 1P RT gave
improved purity and higher molecular weights over the well-established room
temperature two-step (RT 2S) method that is routinely used in the literature. Despite the
fact that the molecular weights of the polyphosphazenes synthesized using these two
methods were lower in comparison with the literature, they were a step towards
polyphosphazene synthesis that did not require advanced synthetic chemistry and
expensive laboratory equipment. These two new methods (polymerization and one-pot
substitution) were then employed to fabricate novel functional co-substituted poly[(amino
acid ester)phosphazene]s with functional handles for biomolecule immobilization. Prior
to the co-substitution, Boc protected glutamic acid ethyl ester was successfully
synthesized via the esterification of Boc-Glu(OBzl)-OH with ethanol, a feat that had yet
to be accomplished. The newly synthesized Boc-Glu(OBzl)-OEt was then deprotected
and used in a substitution reaction with poly[(dichloro)phosphazene] to give a family of
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novel functional co-substituted polyphosphazenes based on L-glutamic acid, L-alanine,
L-phenylalanine, and L-methionine. A step-wise substitution method was developed for
the formation of these novel polymers, where the non-functional amino acid ester was
partially substituted, followed by complete addition of stoichiometric amounts of the
functional glutamic acid substitution, and finally fully substituted by addition of excess
non-functional amino acid ester. These new materials were fully characterized using
FTIR, NMR, TGA, DSC, and GPC. Unfortunately, the polymer backbone was affected
when hydrogenation of the benzyl protecting group was attempted and further work in
this area is required before biomolecule conjugation can be successfully achieved
although similar materials with allyl protecting groups are expected to overcome this. As
it is important that these materials be biocompatible for use in vascular tissue engineering
applications, their cytotoxicity and cell proliferation characteristics were evaluated using
MTT assays and confocal imaging of immunofluorescently tagged cells. MTT assays of
the non-functional and functional polymers showed non-cytotoxicity of the
preconditioned two-dimensional films towards NIH-3T3 mouse fibroblasts over a study
period of five days. The MTT assays also showed enhanced cell attachment at Day 1
versus TCPS positive controls for the PP-F100 and PP-F90E*10 phenylalanine-based
polyphosphazenes and significant metabolic activity of cells seeded on these materials,
which is promising for their use in biomedical applications. Lastly, electrospinning was
used to develop fibers from the new polyphosphazene materials. While preliminary trials
with PP-A100 alone were unsuccessful in fabricating fibers, a 50% PP-A100 and 50% PCL
blend was effectively used to develop fibers at a polymer concentration of 5 w/v % in
DCM. These fibers were then imaged using scanning electron microscopy (SEM) to
show the bead-free morphology and nanometer-scale diameter of the fibers. It is
important that biomaterials can be processed into desired configurations for use in
biomedical applications and in this study not only 2-D films but also 3-D fibers were
successfully fabricated based on the poly[(amino acid ester)phosphazene]s and blends
thereof. Overall, this work suggested that poly[(amino acid ester)phosphazene]s can be
synthesized in non-inert atmosphere and that non-functional and functional co-substituted
polyphosphazenes based on L-phenylalanine ethyl ester may be suitable for biomedical
applications such as tissue engineering.
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5.2

Future Directions

In light of the work presented here, future work on this project should include:


Substituting the benzyl group with a different protecting group like allyl and
deprotection with Pd(PPh3)4 catalyst, followed by conjugation of a biomolecule
known to enhance cell-material interactions



Performing

electrospinning

trials

with

a

rotating

mandrel

for

100%

polyphosphazenes polymer solutions or optimization of the electrospinning
process for polyphosphazenes/PCL blend materials


Performing in vitro degradation studies on two-dimensional polymer and threedimensional non-woven fibrous mats from electrospinning



Performing long-term in vitro cell studies using not only fibroblasts but also
other native blood vessel cells, like endothelial cells and vascular smooth muscle
cells, on 2-D films and 3-D mats of the non-functional and functional poly[(amino
acid ester)phosphazene]s



Perform mechanical testing (cyclic loading tensile testing) on 2-D films and 3-D
fibers of the poly(amino acid ester)phosphazene materials to ensure
appropriateness for vascular tissue engineering applications
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Appendices
Appendix 1: Summary of literature values for the characterization and thermal
properties of poly[(amino acid ester)phosphazene]s. GPC data are relative to
polystyrene standards in all cases.
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Appendix 2: Enlarged regions of the PP-A100 FTIR spectra showing P=N and P-NH
peak broadening. The spectra correspond to L-alanine ethyl ester hydrochloride
(black), and PP-A100’s made by the LT 2S (blue), 1P RT (green), RT 2S (red)
reactions.
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Appendix 3: Enlarged regions of the PP-F100 FTIR spectra showing P=N and P-NH
peak broadening. The spectra correspond to L-phenylalanine ethyl ester
hydrochloride (black), and PP-F100’s made by the LT 2S (blue), 1P RT (green), RT
2S (red) reactions.
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Appendix 4: Enlarged regions of the PP-M100 FTIR spectra showing P=N and P-NH
peak broadening. The spectra correspond to L-methionine ethyl ester hydrochloride
(black), and PP-M100’s made by the LT 2S (blue), 1P RT (green), RT 2S (red)
reactions.
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